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DETERMINANTS AND POLICY IMPLICATIONS OF
DRUG UTILIZATION IN THE PHILIPPINES
Ma. Cristina G. Bautista*
L INTRODUCTION
The drug question has emerged as the central issue from which current health concerns in the
Philippines are hinged on. With the formulation of the National Drug Policy and the legislation
on the Generics Act, the supply of appropriate drugs --those of the right kind, quality and
quantity which can be sold at reasonable prices--has been a key strategy of the government's
health program. The highly charged discussions that accompanied the passage of the Generics
Act into law indicate that the reorganization of the drug supply system to meet the people's needs
is by no means an easy task.
Much of the arguments have focused on the gap between the health needs of Filipinos and
existing systems of pharmaceutical development, promotion, marketing and distribution. Yet,
while much is known about the latter in the works of Gabunada (1983), Sepulveda and Meneses
(1980), and Kintanar and Chanco (1979), discussions on household utilization of pharmaceuticals
have received scant attention (Hardon 1987). Studies on pharmaceuticals have concentrated on the
supply side or the industry level and little is known about the demand side. A study on drug
consumption behavior is necessary to anticipate the likely effects of policies on the users. While
policies are seen as regulations on the industry and the prescriber, it is private or household
consumption patterns that are of interest in terms of welfare. The decision algorithm of
households in relation to pharmaceuticals provides insights into general household health-
seeking behavior.
The ultimate objectives of rationality and efficiency in medicine use should spring from an
understanding of how and why medicine is used. As such, knowledge about prescriber behavior
*_ssistant Professor, Deparlanent of Economics, Ateneo de Manila University.
2is also essential.Even if one were to control the factorsorsocioeconomic characteristicsaffecting
drug use, differentials in use attributedto physician characteristics would remain (Rabin and
Bush 1974). The prescriber's influence needs to be examined, especially in the context of the
• appropriatenessof drugutilization.
It is in this overall contextthat thisresearchon drug utilizationwas undertaken.Specifically,
the study addresses the following questions: 1) Whatare the determinantsof private/household
drug utilizationin the country? 2) What aspects of prescriber behavior influence current drug
utilizationpatterns?3) How can policies affecting the supplyand distributionof drugs affectdrug
utilization?
Aside from the sample surveyof householdsand prescribers,the studyalso examines aspects
of drug supply and distribution from the broaderpicture of the pharmaceutical market. The
analysisprovides alink to thepolicy optionspresentedin thelast chapter.
This report is organized into four parts as follows: the first discusses the framework and
results of the study on householddrug utilization; the second presents the framework and results
of the studyon physician presCriberbehavior, the thirdprovides a brief overview of macro issues
affecting druguse and supply; and the last examines the policy implications of the study.
A. Starting Points
The analysis on patterns of drug utilization begins with an examination of the nature of the
product. Medicines have properties that make it unlike any other commodity. First, unlike other
consumer goods, the demand for drugs is derived. It is not bought for its own sake but for what it
can do to alleviate pain orpromote good health.
Second, while the choice of output, which is better health, is clear, consumer knowledge on
the type of drug to purchase is generally inadequate. A consumer needs to consult a physician
first before making a purchase. In a sense, there is no direct consumer control over the purchase
of drugs. It is the physician, by virtue of his training and prescribing authority, who becomes the
principal d_ision-maker and dominates the demand for drugs(Leifman-Kei11973).Drugs which
require .prescribingauthorityarecalledprescribed medicines.
Third,medicine formsjust one of the many inputs to better health, which include physician
services and hospital treatment, among others. While medicine complements other health care
activities, there may be some substitutability involved. Instead of seeking primary health care
assistance from a prescriber, the consumer may directly purchase medicines. Drugs purchased
without priorprescriptionare called nonprescribedor over-the-counterdrugs.
These unique properties of drugs create implications for drug utilization. Incomplete
information leads to some adverse selection problems wherein the exact quality and quantity of
the commodity to be purchased is unknown. Such situation may lead to under- or
overconsumptionand inapplicability to ailments, among others.While prescribers may influence
actual purchase, they do not carry the burden of shouldering the costs of purchase. Consumer
ignorance and the hazards associated with providers' competencemake the problem of choice in
the pharmaceuticalmarket a costlyenterprise.
Producers (drug companies) provide a wide range of choices for the consumers and
prescribers to choose from. They possess complete knowledge of their products and protect that
knowledge with patents and trademarks. As sellers, demand for their products may come either
directly from consumers (for proprietary or over-the-counter drugs) or from prescribers. Drug
companies andprescribers enjoy a unique relationship.
The government's role is to provide the legal framework in which choices in the
pharmaceutical market can be made. Its main concern is to ensure that the products are safe and
are used for the purposes indicated. But the government is in a unique position because it is both
producer and prescriber, by virtue of the drugs it purchases and makes available to patients of its
health units.
These considerations signify that there exists certain appreciable differences in drug
utilization, depending upon the interaction of consumers with the market and the prescriber.
Household drug utilization, approached from the perspective of consumer behavior, arises from
variables ranging from perception of need and attitude toward medicines to socioeconomic/
demographic background and supply of health service resources.
Household-physician encounters resulting in a prescription provides insights into the quality
of drug utilization. The other approach to drug utilization is prescriber behavior. The latter refers
to the influence of factors like personal background, attitudes, patient characteristics, and
conditions of practice.
These starting points provide the purview of the subsequent discussions.
H. DRUG UTILIZATION AMONG FILIPINO HOUSEHOLDS
This chapter examines drug utilization and its determinants from the perspective of a
household. It presents a model of drug utilization at the household level and tests this model
using the results of a survey conducted among 270 sample households drawn from the country's
urban and rural areas.
A. Framework of Analysis
The analytic objective of a study that seeks to understand the patterns of using medicine is
one of explaining a behavior. The starting point is the people's perception, rather than some
objective and clinical assessment, of their state of health. The extent to which perceived need is
expressed as a demand for drugs is the subject of this study. Effective demand for drugs is
simultaneously interpreted as utilization of drugs. The basic approach is that of consumer
behavior, wherein perception of need, socioeconomic/demographic factors, availability of health
resources and attitude toward medicine underpin the framework of analysis (Figure 1).
Drug utilization is both a volume and a value concept. This study follows the first concept,
which is similar to that used in the study of Kohn and White (1976). Volume of medicine use
refers to the number of different kinds of medicines taken by households over specified
conditions and time periods.
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5Perceivedmorbidityis thefactorthaturges one to decidewhetherto seek medicalcareor not.
As earliermentioned,no assumptionis made regarding the trueor clinically confh'med state of
health. Perceivedmorbidityrefers to any of the following states:restrictedactivity, severity (state
of being bed-ridden)and chronicity accompanied by discomforting symptoms of pain and worry.
Attitude toward health in general also determines the extent one may turn perception into
effective demandfor medicine. Perceptionof need must be of such severity to warrantconcern
and action.
Studies cited in Kohn and White show a directrelationshipbetweenperceived morbidity and
prescribed medicine use. The same study cites inconsistent associations between levels of
medicine use and perceived morbidity. It notes, for example, that one area reporting a large
number of persons who perceive themselves to be ill also report heavy use of prescribed
medicine.
Demographic determinants, such as age and sex, also explain variations in use. The literature
conf'mns increasing use of drugswith age, with persons aged 65 and above consuming ten times
more than persons belonging to the 15-34 year-old age group. The variation in use of prescribed
and nonprescribedmedicine was also the subject of an inquiry in Australia (Bureau of Industry
Economics 1985). The study shows a high use of nonprescribed medicine among 44 year-olds,
with a switch occurring beyond age 40. However, heavy over=the=counterdrug users are
predominantlyunder40. It also notes that women are heavy users of nonprescriptiondrugs.Other
sources cite heavy use by women of prescribed medicines.
Socioeconomic factors of interestare family income and education. In a system where people
pay directly for pharmaceutical services, the amount of family income should directly influence
drug purchases. Families who are better educated and earn higher income can afford more
medicine. However, they may also be morehealthy andrational users such that they may exhibit
lower consumption levels. This is conf'a'med in a number of countries, as cited in Kohn and
White.
Health insurance reduces financial barriers to health care. Greater consumption in the
presence of health insurance is expected. However, its use in the country is still limited.
The kind and quantity of medicine purchase also depend on the nature of consumer
interaction with the health care system. The organization of general or primary health care
services in an areadetermines to a large extent the pattern of health service use. This is critical in
view of the need for prescribingauthorityin the purchase of some types of medicine.
Having a regular source of health care may induce more contact with a physician, hence,
greateruse of medicine. As the numberof contact with a physician increases, drugconsumption,
following propensities to prescribe among physicians, also increases. The findings in
international study reported in Kohn and White and Rabin and Bush indicate contact with a
physician as a significant predictor of prescribed medicine use. However, data from Australia
(Bureau of IndustryEconomics) revealotherwise.
Also included under this set of variables are the sources of information about drugs. Those
who have more acces_ toperiodicals and otherforms of media arelikely to be influenced by drug
advertisements.
The choice of health care system sought upon perception of illness and the extent to which
self-medication may substitute physician contact depend upon the accessibility and attitude
toward health service systems in general. The presence of pharmacies and health care personnel
other than physicians may create variations in drug utilization. Self-medication is widespread
(Hardon 1987) and it substitutes physician contact, especially in areas where there is no regular
doctor or when previous experience with the doctor is not satisfactory. Traditional practices still
play an important role, especially in the rural areas.
B. Methodology
The basic study design is a survey, with households and individual users as the units of
analysis. The household is considered a major unit of analysis because it is the basic spending
unit when it comes to the purchase of goods and services. Health care decision-making is best
viewed from a household's perspective since it is the household which maximizes welfare,
subject to the constraints and opportunities defined by its endowments (Hen-in and Bautista 1989).
For Filipino households, health care decisions are family decisions. The female household head is
usually responsible for every member's health since health expenses are taken out from the
family purse which she holds.
The individual user as a unit of analysis also provides meaningful insights into questions on
anxiety and other aspects of perceived morbidity as they relate to drug use. The nature of the
relationship is further postulated to be subject to household decision-making in the context of its
socioeconomic characteristics.
C. The Survey Design
The survey covered both rural and urban subsamples. The communities were chosen on the
basis of personal contacts and varying proximities to vital centers of commerce and government.
All in all, three urban and four rural barangays (the smallest unit of government) were chosen.
After identifying the communities, sampling was carried out in two stages: first, a cluster
sampling then a random sampling of households. Prior to the selection of sample respondents in
each study area, two types of information were obtained from barangay or health officials: a map
and the number of households in the area. In cases where no maps were available, area layouts
were illustrated in close consultation with the officials or area contacts. The areas were divided
into clusters, often coinciding with barangay zones. Clusters were numbered and "raffled-off' to
the interviewers. At the onset, the interviewers were limited to ten households or a maximum of
five households in each cluster.
With the sample cluster, the interviewers located the cluster's center spot and chose the
household immediately to the right as the starting point of the sample household selection
process. Moving right symmetrically from the first sample household, they then chose the
succeeding respondents at a one-house interval from the last house sampled. In cases where the
area sub- divisions were not well-defined, particularly in dispersed or overcrowded communities,
interviewers were asked to follow a nonlinear pattern yeherein the households chosen did not just
come from one cluster.
Only one respondent from each household was interviewed--the household head or his spouse
or a responsible adult member. Since the interviews were conducted in the respondents' homes,
details regarding use by one individual were ascertained from the individual himself.
Surveys of this type invariably have more low-income than well- off respondents. The former
are more congenial and accessible to interviews. To provide a basis for comparison, a separate
survey was conducted for rich households. Respondents were chosen from among the households
of students of the dite school Ateneo de Manila University. However, the interview, using the
same questionnaire, was self-administered. In a sense, the response may not be directly
comparable. In the analysis, data from rich households are shown just to highlight certain issues.
Community-level data were also gathered to determine community health service systems, for
instance, the availability of health clinics (private or public), pharmacy and health personnel other
than doctors, including traditional healers. In areas where such services are available, household
respondents were noted to be no farther than 30 minutes away.
Household medicine use was examined in two ways: in relation to specific conditions and in
relation to drug types. Regarding specific conditions, medicine use was investigated for any of
the following conditions during the past year: cough with phlegm, chest pains, shortness of
breath, and pain in the joints. Regarding drug types, information on the use of any of the
following drug types for the past month were gathered: pain killers, cough, colds, skin and
stomach remedies, sleeping pills, tranquilizers, vitamins, medicine for certain heart conditions,
contraceptives and others.
Along with the information on use, details were also asked regarding visits to the physician
for the past month, if medicines were prescribed during these visits, hospitalizations (other than
giving birth), number of sick family members during the past month, sources of information on
drugs (other than the physician), preventive care and socioeconomic data.
D. Analytical Tools
The model was tested using multiple regression analysis and multiple classification analysis
(MCA). The latter was first brought the author's attention by the international study of health
care utilization described in Kohn and White. Given certain behavioral and other variables
expressed in more than one category, the MCA served as an appropriate tool for analysis. It
follows an analysis of variance procedure but yields estimates of regression coefficients. Unlike
multiple regression techniques, even variables measurable on interval scales have to be collapsed
into a smaller categories. The software utilized, though, could accomodate only a maximum of
ten independent variable entries.
E. Results and Discussions
Patterns of Drug Utilization. Table 1 shows the distribution of our respondent households by
study sites. Rural households comprised 55.9 percent of the sample and urban households, 44.1
percent. Rich households comprised only 7.4 percent of the total number of respondents.
The extent of household medicine utilization is shown in Table 2. Prescribed medicines
comprise a larger percentage of total medicines used. More urban households use prescribed
Table I: Distribution of Household Respondents by
.Study Sites
Nt_mber of
Areas : Households Percentage
Navotas 39 14.4%
Las Pinas 26 9.6%
Quezon City 34 12.6%
"Rich" 20 7.4%
Total Urban Sample 119 44.1%
Tarlac 30 1i.1%
Pampanga 41 15.2%
Nueva Ecija 30 II.1%
Laguna-Cavlte 50 18.5%
Total Rural Sample 151 55.9%
TOTAL SAMPLE HOUSEHOLDS: 270 I00.0%
medicines than rural households. The rate of household drug consumption is 6.5, 4.4 and 6.0 for
urban, rural and rich households, respectively. The difference .in the rate of use between
prescribed and nonprescribed medicine is not substantial in rural households, unlike in the two
other household types.
The widespread use of prescribed medicine may be contrary to expectations. Total medicine
use was asked in two contexts: one, in relation to the four conditions and the other, in relation to
drug types. Regarding drug use in relation to the four conditions, drug-use information followed
the question on the use medical personnel. Afterward, the respondent was asked if the medicine
named was prescribed by any of the medical personnel. References from nonmedical personnel
were not considered as prescribed. Better recall for condition-related use is expected. However,
the use of a one-year recall period may account for certain slippages of memory. A longer recall
period seems justified in the context of specific health conditions. However, the question on
health service or personnel utilization would provide appropriate checks. Regarding drug use in
relation to drug types, the phenomenon of repeat prescription (previous prescription used for
•recent purchase) has not been thoroughly delved into. But as in the first situation, references were
asked regarding the source of prescription. However, certain cultural biases that may prompt
• some to respond in what they expect to be the correct answer--that medicines should be
prescribed--could not be discounted.
Furthermore, the results should not be construed as implying greater access to health services
or personnel. It is possible that due to the longer recall period, a visit may have occured
considering that drug use was related to specific ailments. With the relative poverty in most of the
study sites, medical missions conducted by charitable institutions are possible.
The breakdown of total medicine use by therapeutic class is shown in Fig. 2. The "Othersd"
category is the biggest grouping. It includes medicines •inadequately named, as well as home or
herbal remedies. Analgesics form the second largest grouping of household medicines used,
followed by cough/cold remedies.
Drug consumption for the past month for 10 specific categories of medicinal substances is
shown in Tables 3 and 4. For prescribed medicine use, 56.6 percent of urban households use
vitamins, followed by cough medicines and pain relievers. Rural households, on the other hand,
purchase more vitamins, cough and stomach remedies. Vitamins surface as the prescribed item
purchased the most by the cross-section of households. This provides a clue to prescribing
patterns.
For nonprescribed medicine use, 38 percent of urban households use pain killers, skin
ointments and cold •remedies. On the other hand, 48 percent of rural households buy pain killers
over the counter, followed by skin ointments and cold remedies. Cold relief medicines, followed
by pain killers and cough medicines, are the major over-the-counter purchases of rich
households.
Physicians are the major source of drug information (56 percent of all medicines used for the
past month) for households, followed by friends and relatives (15 percent). Self-prescription
knowledge, drugstore personnel and advertisements form the other major sources of drug
I0
Table3: DistributionofHouseboldeReporting
PrescribedHedicineUsebyCategoryofMedicine
PastMonth,inPercent
Birth
Area : Pain Cou_h ¢_lde Skin Gtosach _leep Tranqzre Vitesine Heart Control Others_
• . _ ........... |
............. t ........................................................................................
flavotae _ 28.2 46.2 20.5 12.9 23.1 2.6 7.7 41.0 15,4 5.1 -
LaePinna I 19.2 38.5 26.9 20.8 30.8 3.8 3.8 69,2 7.7 15.4 3.8
QuezoeCity I 26.5 55.9 20,6 32.4 14.7 2.9 84.7 11,8 5.9 8,8
Tarlac I 6.7 16.7 6.7 3.3 6.7 3.3 - 33.3 10.7 3.3 8,0
Pampanga _ 7.3 24.4 2:4 9.8 14.7 - 22,0 17.1 2,4 2.4
NuevaKcl_a _ 6.6 16.7 3.3 3.3 23.2 - 33.3 30.0 - 0.7
Laguna-Cavite_20.0 20.0 14_0 2.0 12.0 - L2.6 2.0 - I
! !
! !
Urban I 25.3 47.4 22,2 24.2 22,2 3,0 5.0 56.8 L2,1 8.0 4,0
Rural _ 11.3 19.9 7.3 4.6 13.9 ... 23.2 13.9 2,0 3.3
t
I
Rich ' 30.0 30.0 10.0 20.0 35.0 5.0 35.0 30.0 - - 'o t
Table 4: DIstribution of goueekoldslelmrtin_
lion-Prescribed_li¢lue Oneby Categoryof Ilecliciue
Purl Ioath, in Percent
Birth
Ares _ _i_ Co_Kh Colds Skin Stouach _ieep Truqses Vitmiu Unapt Co_trol Otheen_
............. # .......................................................... i
Nnvotae _ 30.8 7.7 20.5 33.3 12.8 2.8 2.6 12.8 2.6 - *,
LaaPinna _ 38.5 15,4 42_3 34.8 15,4 - - 3.8 - 3.8
QuezonCity : 47.L 14.7 17.7 29.4 20.8 - - 14_7 - 8.8 :
Tarla¢ : 63.3 .23.2 13.3 23.3 30,0 - - 6.6 - 8.8 6.6
Pssp_a _ 68.3 22.0 34,1 22.0 20.2 - -. 1985 - 2.4 2.4:
leuevnkija _ 53.3 20.0 30.0 33.3 8.7 - - 16.7 - 3.3 6.7
_a_ma-Cavite_ 20.0 10.0 14_1 26.0 8,0 0,02 - 10.0 0.02 - I| e
!
Urban : 38.3 12.1 25.3 32,3 18.2 1.0 1,0 LL.I 1.0 - 7.1
brsl ' 48.3 17.9 22,5 25,8 17.2 ...... 13,2 ... 2.8 2.6
, I t
|
lich ' 35.0 35.0 40.0 15.0 15.0 30.0 5.0 5.0
Lepnd:
- lern gee
,.. Lenathan lZ
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information(Fig. 3). Self-prescriptionknowledgeis defined asprevious experience with thedrug
underconsideration.
Thevarious sourcesof druginformationarcshownin Table5. Advertisementsanddrugstores
show similarpatterns of distributionamongmedicine types. Drugstores are the direct source of
information on sedatives, tranquilizersand contraceptives. Informationon medicine for skin
ailmentslargelycome from traditionalsources.
Perceived Morbidity and Use. In termsof morbidityprofile, the sample households are fairly
weU-distributedacrossthe categoriesnamely:handicap/disability, chronicor recurringailments,
indicator complaints (chest pains, cough and phlegm, shortness of breath and joint pains),
hospitalizationand illnesses otherthanthe four complaintssufferedduringthepast month.
Table 6 shows the distribution of householdsamong these categories.If the table indicates the
health status of the sample population, thenmorbidityconditions in urbanareas are much worse
thanin theruralareasfor all categories exceptdisability. Only slightly morethanone thirdof the
richhouseholdsreportedgetting sick for the pastmonth. Most of them reportedone or two of the
four indicatorconditions.
The rate of medicine use accordingto healthstatus is shownin Table 7. A fourthto a fifth of
the total numberof medicines used by all household respondentshave been used for any of the
four complaints. Residual intake refers to the ten medicinal substances (for cough, pain, etc.).
Medicine intake for "healthy" households which reported no sick member for the past month
indicates the use of medicines for preventive care. When the total medicine intake for the four
complaints was summed up and divided by the total number of households which reported
suffering any of the four complaints, figures yielded medicine use of 1.6, 1.5 and 1.0 for urban,
rural and rich households, respectively.
Focusing on persons with complaints, the rate of use by morbidity levels shows that some
persons suffering from the conditions identified do not have the benefit of pharmaceutical
treatment. This is shown by the less than one correspondence between total medicines used for
the four complaints and total number of persons with complaints (Table 8). There are still ill
people in the rural areas who do not have the benefit of medicines, especially those suffering
from ailments of moderate severity. Compared to urban areas, rural areas have lower rates of
medicine use per person for each morbidity level.
SocioeconomiclDemographic Factors. In terms of age and sex of user, the rate of medicine
use is higher for men than women in almost all areas (Table 9). Less than one correspondence
between total medicines used and number of complainants by sex is more common for female
than male adults. Female children in urban areas have higher use rates than their counterparts in
rural areas. Per personuse of medicine is higher for male than female children in the rural areas.
The per capita use of medicine by sex and age structure can indicate if there is a tendency
towards polypharmaey (excessive medicine intake or over-prescription). Results show that every
complainant takes at least one medicine for an ailment. The appropriateness of use cannot be
verified.
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Figure3
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Table 5: Sources of Drug Information
Type of Not Presc Albu- Agent Friends Self Drug
Medicine Inducted by Dr. Media laryo Sample Family Presc Store
Pain Relievers 1 71 37 1 0 51 33 22
Cough 2 114 12 3 0 19 9 8
Cold 3 42 14 1 0 23 17 13
Skin 6 47 13 7 4 33 17 13
Stomach 0 75 3 4 0 20 10 14
Sedatives 0 5 0 0 0 0 0 2
Tranquilizers 0 5 0 0 0 0 1 0
Vitamins 8 140 8 3 2 16 3 I0
Heart/Blood 1 55 0 0 0 1 1 0
Contraceptives 0 13 1 0 0 2 0 1
Table 6: Distribution of Households in
Morbidity Categories (in percentl
' ii I 21 ' 3/ 4/1I ! ...
Area Handicap/ IChronic I Four iHosptlznl Sick I
Disability:Complnt IComplnt ' ' '! i I
_. I I I II ! I f
Navotas 7.7 I 53.8 I 94.9 _ 6i.5 I 53.8 I
[ms Plnas 7.6 _ 38.5 I 80.8 I 69.2 I 80.8 I
Quezon City 8.8 I 17.6 I 76.5 I 38.2 I 23.5 I
Tarlac 16.7 I 20.0 : 80.0 : 36.7 I 33.3 I
Pampanga 1.4.6 I 17.1 _ 73.2 _ 31.7 I 29.3 I
Nueva Ecija 16.7 I 36.7 I 43.3 _ 33.3 I 33.3 I
Lag%ma-Cavite: 14.0 I 32.0 I 76.0 I 40.0 I 28.0 I
i I I ! I
¢ i i ! i
Urban 8.1 I 37.4 I 84.9 I 53.6 ] 50.5 I
Rural 15.2 I 28.5 I 76.2 l 38.4 _ 31.1 I
I I I I I
i ¢ i , i
Rich 10.0 I 5.0 I 25.0 I 20.0 I 35.0 I
i: Defined as a long-standing, recurring ailment.
2: Percentage of families with at least one member
complaining of coSgh and phlegm, pain in the
joints, chest pains and shortness of breath
for the past year
3: Reference period: 3 years, hospitalization
not related to childbirth
4: Defined as not feellngwell for the past month
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Table 7: Percentage of Medicine Used
by Health Status Categories
Total _ % for 1% for *:Residual
Area: % Med Used 14 complnt _ Healthy
| I ....... ___
! i
Navotas 100 226 ' 33.2 ' 3.1 63..7
Las Pinas 100 163 ,' 16.6 ,' 13.5 69.9
Quezon City 100 215 _ 14.9 _ 17.2 67.9
Tarlac 100 133 ,' 27.9 ,' 16.5 55.6
Pampanga 100 208 I 20.7 _ 21.2 58.1
Nueva Ecija 100 157 _ 27.4 I 28.0 55.4
Laglma-Cavite 100 159 ] 30.2 ] 9.4 60.4
! I
i i
Urban 100 644 ', 20.8 ', lO. 2 69.0
Rural 100 661 ,_ 25.9 ,' 15.9 58.2
I I6 !
Rich 100 119 ,_ 4.2 ,' .68.1 27.7 ",
* Did not suffer from any of the four conditions and
answered "No" to the question "Is there any household member who
stayed at home during the past month because he dld not feel
well?
TableS: Rate of Medicine Use of Persons by Indicator
Condition and Morbidity Levels
Restricted Activity Stay In Bed
Indicator
Conditions Urban R_iral Urban Rural
Cough & Phlegm 1.4 1.4 1.4 1.3
Chest Pains I.0 O.8 1.1 I.1
Joint pains 1.0 0.8 1.0 0.9
Shortness of O.6 O.5 O.7 O.6
Bre....
:=====:==:=:==___
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Table g: Medlcine-to-Person Rate of Use.
by Male/Female and Adult/Child
Female IFemale :Total IMale ',Male :Total ITOTAL
Area Chldrn IAdults IFemales IChldrn :Adult IMale '
i • ! I I i I
i ........ t i i j i
Nay.,as 1.3 ', 1.4 I 1.4 : 1.2 ', 1.2 I 1.3 I 1.6
Las Pinas 1.2 I 1.1 I 1.2 : 1.0 : 1.0 ', 1.2 I i.I
Quezon Cit.v 1.3 ', 0.5 I 0.7 : 1.5 I 1.5 : 1.4 '. 1.0
Tarlac 2.0 i 0.9 °, 1.2 I 1.2 ', 1.2 : 1.3 : 1.4
Pampanga 0.6 I i.i I 0.8 I 4.0 ', 1.0 ', 1.3 I 1.3
Nueva Ecija 1.6 : 1.3 ', 1.4 I 3.0 _ 1.4 ', I..8 ', 1.7
Laguna-Cavite 1.8 : 0.8 : 1.0 I 0.5 : 0.9 : 1.4 : 1.6
! i i , i i
# , , , u i
Urban 1.3 I I.i ', 1.2 ', i.i I 1.3 i 1.3 ', 1.3
Rural 1.5 ', 1 ', 1 ', 1.8 : 1.1 ', 1.5 I 1.5
, I , i i I
! t q o ,
, l I ! I ,
o f i i ;
Table I0: Percentage Distribution of Medicine Use by Type,
By Educational Level of Household Head
% % % %
of HH of total of Presc of Non_resc
Respondts Med Used Med Used Med Used
Primary 48.1 48.2 49.3 46.7
Secondaz_ 27.4 27.7 25.6 30.5
Collegiate 14.1 14.9 16.0 13.5
Vocational 4.8 3.7 4.4 2.8
No gPade 5.5 5.4 4.7 6.5
reported
100% 100% 100%
Use of Prescribed and NonpPescrlbed Medicines
per Educational Level
Primary Sec'ndry Collgte Voc _1 No Grade
Prescribed 58.9% 53.3% 61.6% 67.9% 49.4%
Nonprescrlbed 41.2% 46.7% 38.4% 32.1% 50.6%
Total I00.0% !00.OX I00.0% I00.0% 100.0%
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The differential in male-female use rates is interesting because it contrasts with observations
in the literature. That the medicine needs of men are met more than that of women may be due to
the cultural perception that their needs are more important, men being the family breadwinner.
Thus, any absence from work due to sickness may cut down family income. The household
simply cannot afford a sick breadwinner.
Differences can also be attributed to morbidity differentials between the two sexes. Work
outside the home may expose men to more health hazards. However, data reveal that although
more men have complaints compared to women, the difference is small. For the four conditions,
male complainants exceed the number of female complainants in all categories except shortness
of breath. Many of the women's complaints on shortness of breath may be a cause for mild
concem.
The rate of drug utilization by educational level of household heads is shown in Table 10.
The use of drugs shows no marked difference across all educational levels. The distribution is
skewed in favor of prescribed medicine, except for those who did not report a schooling level.
The lowest overall rate of use was registered by households headed by vocational school
graduates. Households headed by primary school dropouts or graduates have higher rates of
medicine use.
In terms of income, the poorest groups, also the largest, account for 62 percent of total
medicines used (Table 11). The higher income groups, though smaller in number, account for a
greater percentage of total medicines used. It is worth noting that most of those who did not
report their incomes are from the rich household samples. If medicine is to be considered a
resource or input to better health, then there seems to be an uneven distribution of it. Taken in the
context of the results on per capita use, this distribution pattern conf'u'rns that the poorer groups,
with more complainants, have less access to medicine. Although it cannot be verified if each
complainant does need medicine use, since no clinical examination has been taken.
However, from the profile of use (shown in Tables 3 and 4), vitamins was widely prescribed
to both groups indicating preventive use. As a percentage of total medicine use, the use rate of
those who did not report income and the middle-income earners shows a skewed pattern in favor
of prescribed medicine. For nonprescribed medicine use, the rich tend to use more cold and
cough remedies, while the poorer ones tend to use more pain relievers. This connotes some
degree of substitutability, with medicine substituting for other forms of therapy, such as
physician consultation and the like.
Health Service Availability and Use. No clear pattern emerges when health service use is
related to drug consumption. Table 12 shows that urban areas, which have the largest percentage
of families with physician contact for the past month, have higher medicine use rates than rural
areas. On an area basis, both Navotas and Quezon City have high medicine use rates. However,
Navotas has the second highest physician contact rate, while Quezon City has the second lowest.
More households have drugstore or pharmacy contacts. Between urban and rural areas, a
larger percentage of urban households have drugstore contact, similar to the patterns shown for
physician contact. The area which showed the highest pharmacy contact has the second highest
medicine consumption. No clear relationship is shown between drugstore contact and the number
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Table Ii: Percentage Distri_ition of Medicine Use b,vTy_e
by Annual Income Class
% % % %
of HH of total of Presc of Nonpresc
Resp Mad Used Med Used Med Used
No Income Reported 2.9 4.8 6.3 2.8
P 36.000 down 67.8 62.0 60.1 64.7
P 37.000 - 90.000 21.5 23.3 23.9 22.5
P 91.000 up 7.8 9.8 9.7 9.9
100.0 100.0 100.0 100.0
No Income P 36.000 P 37,000 P 91.000
Reported down to P90.O00
Prescribed 75.6% 55.8% 59.0% 57.1%
Nonprescribed 24.6% 44.2% 41.0% 42.9%
Total 100.0% 100.0% 100.0% 100.0%
Table 12: Health Service Attributes and Use
w
Number of: :_ Percent of Families with: _I Rate
_i " ofe,e
Health Pharma- _IHealth Physician Pharmac_ _ Use of
Area Centers cies _: Insur. Contact Contact _ Med.
It II
if 00
Urban: '* '*OI |$
Navotas 2 3 _ 2.6 25.6 84.6 _ 5.8
Las Pinas 2 3 _ 23.0 38.5 96.8 ,,'' 6.3
Quezon City 8 4 _: 67.7 8.8 74.5 I_ 6.3
II If
1¢ l*
Rural: i, ,*
Tarlac 2 0 _ 16.7 13.3 90.0 _} 4.4
Pampanga 3 2 II 14.6 17.1 68.3 II 5.1
Nk,evaEcija 3 i :_ 6.7 16.7 80.0 II 2.3
Laguna-Cavite 5 4 :: 3.6 6.0 74.0 _: 3.2
11 iI
It _|
Urban 19 6 II 24.4 23.2 82.3 II 6.5
Rural 6 8 II 10.4 13.2 76.8 ii 4.4
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of drugstores in an area. It is important to note that what are referred to as pharmacies are really
just drugstores.
That more households reported more pharmacy use than physician contact indicates
substitutability between pharmacy and physician contact. The extent to which the most recent
physician contact resulted in a prescription cannot be directly verified.
Data on health insurance show that it comprises only 24and 11 percent of urban and rural
households, respectively. The insurance system referred to is the Medicare program for
government (GSIS) and private (SSS) employees. Only 45 percent of rich households reported
having medical insurance. These small prcentages prompted the author to place health insurance
as a health resource, rather than a socioeconomic factor, which complements income.
Furthermore, health insurance is only meaningful if it features hospitalization benefits which
allow the reimbursement of drug purchases.
Attitude. The objective for this part of the study is to gain an attitudinal profile of the
respondents. While no direct links have been established between drug use and attitudinal
variables, the distribution of responses to certain variables provides insights into our respondents'
valuation of medicines or physicians, as well as their health-seeking behavior. Certain statements
reflecting physician-related perceptions and utilization behavior were presented to the
respondents, requiting a "yes" or "no" reply. The responses in Table 13 reflect a fairly typical
outlook toward doctors and medicine use. The respondents are fairly well:aware of the
advantages of modern medicine (#1), respectful of and dependent upon doctor's opinions (#2-4,
7), yet discerning of their physicians(#5-6) and medicines (#8) or even independent (#9-10).
Their responses may be linked to their socioeconomic background, as well as experiences with
the health care system in general.
The following points are worth highlighting for their implications on policy. More than
two-thirds of the respondents do not believe that the cheapest drug is as effective as its expensive
counterpart. There may bea problem with therapy compliance, with the respondents closely split
on whether they should continue or discontinue use of medicine despite medical advice. There
may be a need for an educational campaign on the role of doctors and medicines, since more than
two-thirds of the respondents believe that doctors who do not issue prescriptions are less
competent than those whodo. This may provide a clue as to why doctors behave this way.
Determinants of Use. Medicine use is defined as the different kinds of medicines households
reported they have taken for the four complaints, as well as for 10 medicine types. They were
estimated for either individual or household use. The runs presented in this study comprise the
best of the numerous estimates done. The ultimate concern is to present the estimates that
validate the model used and at the same time present policy handles.
Initially, an MCA of the determinants of total medicine use by the household (for the four
complaints and by medicine types) was undertaken. The variables identified in the model were
included. Only four factors appear to be significant (presence of chronic complaints in the family,
presence of illness, location and reliance on prescribed medicine over home remedies). The
model explains only 19 percent of the variance. Morbidity is the most significant explanatory
factor (Table 14).
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Table 13: Attitudes and Behavior Profile
Percentages
Statement
Yes No
I, Drugs doctors prescribe 82.9 15.5
are better than home remedies.
2. Doctors should give 98.5 1.5
details of what he is doing to
you, the patient.
3. Following a doctor*s advise 87.8 12.2
will give one less illness in
one's lifetime.
4, Do you doubt some of the 11.5 87.8
things doctors say they can do?
5. It is best to try different 58.5 40.4
doctors to find one who will give
the best care.
6, Is it sometimes good to 34,4 65.2
suggest treatments different from
those _he doctor prescribed?
7, When a doctor prescribes 58.9 41.1
medicines, do you buy everything
at once?
8. The cheapest dmlg is as 30.7 68.1
effective as its expensive
counterpart.
9. The person in the botica 15.2 83.7
is Just as good as the doctor.
i0. When you start getting well. 49.3 50.4
do you usually discontinue the use
of prescribed medicine even if the
doctor says you have to take a
specified amount?
II. A doctorwho does not 75.9 23,3
prescribe a medicine upon
consultation is not a good doctor,
2O
Table 14: Proportion and Relative Imvortance of Variables
in Explaining Variance in Total Medicine Use
by All Respondent Households
Proportion Relative +
Predictors of Variance Importance Significance
Explained in Explaining
Variance
I Eta Beta
I
I
Morbidity Factors
Recurrent sickness 0.23 0.13 **
Illness 0.27 0.29 ***
Use Factors
Doctor present
in commtmity 0.07 0.02
Pharmacy in area 0.12 0.01
Socioeconomic Factors
Annual household
income 0,13 0.08
Educational level
(housewife) 0.08 0.06
Insurance 0.08 0.06
Location:Urban 0.22 0.12 *
Rural
Attitudes
Faith in M.D.s 0.22 0.15 **
Compliance wlth
treatment 0.06 0.03
R squared: 0.192
+Significance levels: * at 10% _ ** at 5% _ *** at 1%
21
The variance in medicine use by individuals having any of the four complaints, as explained
by another set of selected variables, is quite large (Table 15). This is shown by the high R
squared. The variance in medicine use, as explained by the eta, is attributed mainly to morbidity
and demographic factors such as sex. The corresponding beta coefficients indicate the significant
role of sex of user in explaining the variance in utilization. In this case, women's consumption
largely influenced the variance in use. Anxiety over a health condition is also a significant
determining factor in medicine use.
Using similar sets of variables, the author sought to explain the variance in use by adults with
any of the four complaints (Table 16). Although the explanatory capacity (eta) of the individual
predictors is quite modest, they are well distributed among the variables. Health service factors,
thepresenceofa pharmacyinthevicinity,and theavailabilityofa healthcentercontribute
greatlyinexplainingmedicineuseamong adults.Drug utilizationandhealthserviceattributes
complementeachother.Anxietyandsexagainemergeasimportantpredictors.
The MCA providesa simplepictureoftherelationshipbetweendrugutilizationandselected
predictors.Itisusefulespeciallyifthevariablesarecategorical.But thesoftwarelimitedthe
authortotenindependentvariables.Beyondthatmultipleregressionhadtobcusedtocapturethe
directionfinfluenceofthefactors,aswellastheirsignificance.Onlytherunsdoneformedicine
use by medicinetypeswere acceptableand fitforthemodel used and forstrongpolicy
implications.The choiceoffinalvariablesweremade afterseveraltrials.Only thosewhich
explain a greater proportion of the model are presented.
Table 17 shows the results of the regression analysis on the determinants of drug utilization
for households. Location is highly significant in explaining total medicine use. Total
consumption varies indirectly with urban use. An explanation for this may be related to the nature
of morbidity conditions, as well as the relative poverty, in urban areas.
In all three areas, drug utilization varies directly and significantly with the proportion of
prescribed to non-prescribed medicines. This variable shows the degree of influence of prescribed
medicine use to overall household medicine use. Households which reported a greater share of
prescribed medicines to total medicines used are likely to utilize more. This is probably because
of greater valuation of the role of medicine in general since "authority" (prescriber) has confirms
it. This view is supported by the significance of physician contact or doctor consultation for
urban and overall use. Physician contact generally results in the issuance of a prescription. But in
the rural areas, a significant explanatory variable is media contact. This is quite ironic
considering that media exposure is greater in urban centers. The relative scarcity of physicians, as
well as low educational levels, may account for high media influence among rural people.
The presence of a health center is generally significant. What is perplexing is that the
presence of a drugstore negatively influences drug utilization. The variable "drugstore" refers to
its presence in the community, not to utilization. The distinction between supply and utilization
needs to be made. It is possible that more progressive areas have more drugstores but better
health status, hence the lesser need for medicine use.
Household size, a demographic condition, is another significant factor in both urban and rural
areas. The bigger the household size, the more medicines consumed. The more dependent
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Table 15: Proportion and Relative Importance of Variables
in Explaining Variance for Individuals
with any of the Four Complaints
', Proportion Relative +
Predictors I of Variance Importance Significance
',Explained in Exp_laining
' Variancet
' Eta Beta
I
t
Morbidity Factors ',
Bed stay : O.76 0..37
Anxiety I O.74 O.61 ._*_
f
J
Health 5er Jlce
Pharmacy ', O.12 O. Il
Health center _ 0.08 0.08
I
i
Soc ioeconomic /
Demographic Factors ',
Annual income _ O. 12 O. 13
Educational level ,'
(head) I O.22 O.09
Sex of user ,' O. 73 0 . _a_.' ***
R squared O.626
+ Significance levels: * at 10% : ** at F,% : -_:_"_at I%
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Table 16: Proportion and Relative Importance of Variables
in Explaining Variance for
Individual Use of Medicine, by Adults
i ProDortion Relative +
Predictors : of Variance Importance Significance
',Explained in Explaining
' Variance
' Eta Beta!
Morbidity Factors
Bed stay I 0.09 0.07
Anxiety I 0.40 0.35 _,
I
I
Health Service
Pharmacy _ O, 09 O. 44 _*
Health center I 0.13 0.55 **
I
Socioeconomic/ I
Demographic Factors I
Annual income I 0.23 0.26
Educational level :
(head) : 0.28 0.32
Sex of user : 0.25 0.26
R squared 0.438
+ Significance levels: * at 10% : ** at 5% ; **_ at 1%
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Table 17: .Drug Utilization Regression Results.
Total Medicine Use for I0 Drug Types as Dependent Variable,
Urban, Rural and All-Household Use
Variables Urban Rural A]1-Household
% Presc to NonPresc 0.589 0.910 0.696
(2.804)*** (6.769)*** (5.798)***
Household S_ze 0.398 0.198 0.273
(2.177)*_ (2.429)*** (3.191_***
Drugstore -0.235 -0.149 -0.280
(-0.578_ (-1.106) (-1.894_*
Work of HHead -0.173 0.Ii0 -0.025
(-I.171_ (1.369) (-0_323)
Use of Media/TV -0.564 1.497 0.456
as source (-0.724) (3.309)_** (1.083)
Sick Member 0.976 0.300 0.577
(1.433) (0.845) (1.629)
Doctor Consultation 1.211 0.466 0.758
(1.716)* (I.339) (2.155)**
Mother's Education 0.198 -0.048 0.125
(0.843) (-0.365_ (0.985_
No. of Working 0.156 0.192 0.138
_embors (0_691) (1.513_ (1.1.34)
Presence of Health 0.185 0.214 0.161
Center (0.912) (1.267) (1.669_*
Location: U/R ..... 1.218
(-3.257)***
Percent of HMembers 0.563 0.320 0.133
Aged below 12 (0.213) (2,079_** (0.909)
Constant 2.234 ().316 3.559
(2.150_ (0.442) (4.110_
D.F. 107 139 257
F-value 2.217 9.709 9.367
Adjusted R squared 0.i0 0.39 0.27
( ):T-values _ sig. at le_s 2.5%, ** sig. 5%, *sig. 10%
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children the household has, the greater the use, probably indicating the health status of the
children.
F. Concluding Remarks
The determinants of household drug utilization axe morbidity factors, health service supply,
demographic conditions and certain attitudinal values. That socioeconomic factors do not
significantly explain drug utilization only confirms the relative inelasticity of medicine
consumption to changes in socioeconomic variables. Income and its proxies, like occupation of
household head, number of working members and mothers' education, do not show any
significant relationship with drug utilization.
The perception of need, expressed through some complaint or severity of condition, initiates
medicine use because of the firm belief in its pain-alleviating properties, real or imagined. Health
service supply, referring to health centers or drugstores, may merely facilitate the process.
Utilization varies directly with women's patterns of use.
Data gathered for this study do not reveal strong tendencies towards polypharmaey. For every
complainant, at least one medicine is injested for every ailment. While judgement is not made on
the nature of complaints and the appropriateness of medicine use, this study shows that there
exists some problems regarding access to essential drugs. There are needs that are not being met.
The problem can flow from several sources. There may be economic barriers to medicine use,
although this does not figure prominently in this study's results. Supply of medicines appropriate
to health needs is also another some. People may purchase from what is out there. More
importantly, there may be an information problem. The extent to which formal service units
function as useful sources of information regarding modem medicine use needs to be examined.
The quality of information from such sources needs to be assessed due to the presence of
medicines of questionable therapeutic value, as well as source substitutes;
The significant effect of prescribed medicine consumption on overall consumption patterns
highlights the discussion in the next chapter. Moreover, the predominant use of prescribed
medicine appears contrary to expectations.
Policy assistance is thus needed in the following areas: improvement of drug selection;
accessibility to essential drugs; educational campaigns on proper drug use not only for consumers
but also for providers, including drugstore personnel; and the monitoring and regulation of the
quality and reliability of information regarding certain therapeutic claims and proper prescription.
These considerations are discussed in the last chapter in the form policy options.
ELI.PHYSICIAN CHARACTERISTICS AND PRESCRIBER BEHAVIOR IN THE
PHILIPPINES
This chapter provides a model which describes prescribing behavior in the country. It
presents a profile of Filipino physicians and examines how their characteristics--personal,
practice- and patient-related--affect prescribing behavior.
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A. ConceptuaI Framework
A number of studies have investigated prescribing behavior-- the quality and quantity of
prescriptions--and its correlates. Most of these have been conducted from the perspective of a
developed country. For example, StoUey and Lasagna (1969) cited marketing data which show
prescribing patterns to be inefficacious, inappropriate for the diagnosed condition, or unsafe as
prescribed.
Empirical investigations show results that warrant validation from the experiences of
developing countries. Limited surveys in the Philippines show the prescribing habits to be
inappropriate and often unnecessary (TordesiUas and Gutierrez 1981; Quijano et al. 1985). There
is a need to examine the factors that result in such prescribing patterns.
The framework used in examining prescribing behavior is presented in Figure 4. This report
discusses only the proximate factors and has nothing to say on the medical parameters, meaning
the rightness or wrongness of the diagnosis itself. The latter is somehow reflected in the treatment
advised as well as medication prescribed.
It is hypothesized that prescribing behavior is a product of the interaction of the proximate
variables, composed of the personal characteristics of physicians, conditions of practice, and
patient characteristics.
Prescribing behavior, mirrored in the drug prescription, is defined in two ways: a) the
percentage with which a patient's visit results in a prescription, and; b) condition-related
prescription. The In'st denotes the propensity of Filipino physicians to prescribe during outpatient
consultations. The second examines the first choice drug for certain conditions: ORS for diarrhea,
peniciUin for sore throat, and NSAIDS for muscle pain. ORS and penicillin are generally
considered acceptable choices for the treatment of diarrhea and sore throat, respectively.
NSAIDS may be considered inappropriate for muscular pains on an outpatient basis. By
examining the variables affecting the acceptability of drug therapy choices, insights into the
quality of prescribing behavior are gained.
B. Proximate Variables
Personal background includes variables such as age and sex, quality of training, affiliation,
attitude toward state policy and the drug industry, as weU as perception of the role of
pharmaceuticals in overall medical care. Older physicians are expected to prescribe more
rationally and sparingly due to experience, not only in prescribing a specific drug but also with
various treatment outcomes (Denig et al. 1986).
On the other hand, younger physicians may be more appropriate prescribers as a result of
better pharmacological training and greater awareness of drug issues. Graduates of better quality
schools would generally have better training in pharmacology. Irt a study of primary care
physicians in the U.S., Stolley et al. (1972) formed a panel of,expert judges to evaluate medical
prescriptions. In their findings, they noted that the more appropriate prescribers tend to be the
younger, more recent graduates with some postgraduate ixaining. They possess a more modem
and cosmopolitan attitude and are concerned with tlie quality and psychosocial, rather than
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technical, aspects of medical care. They were found to be heavily reliant upon journal articles for
drug information, more critical of the pharmaceutical industry, and more supportive of the
government's role in regulating drug quafity and costs.
Studies of prescribing behavior in three English towns were also cited, showing that low
prescribing is attributed to high educational qualifications and peer association. Still other studies
cited found prescribing rates declining as the age of the physician increased. Sex was found to be
a significant predictor, withwomen doctors prescribing more often than men. The latter study did
not control for content of practice between sexes (cited in Rabin and Bush 1974). In a study of
prescribing behavior for psychotropic drugs, Hemminki (1974) found that the more positive the
attitude of the doctor toward the use of drugs for social problems and everyday stress, the more
he prescribed psychotropic drugs.
Conditions of practice refer to the physician's location of practice, his patient load per week,
and time spent with each patient. In the Stolley article, physicians who spent less time with
patients and had more extensive practice •with ancillary assistants were found to be better
prescribers.
The type of practice has also been found to affect prescribing. Rabin and Bush (1974) cited a
study done in France wherein general practitioners were found to give higher percentage of
prescriptions compared to consultant-specialists. They also cited another study where high
prescribers were those who had higher rates of patient visits. Since it is commonly believed that a
• physician would look to the prescription as a polite way of ending a consultation, a greater
propensity to prescribe would be expected for those with heavy patient load practices.
Drug-specific studies, like those conducted by Hemminki for psychotropic drugs and Gabe
and Williams (1986) for tranquilizers, yielded interesting findings related to the effect of
conditions of practice on prescribing behavior, Hemminki's study noted that the longer the
surgery hours, the more psychotropic drugs are prescribed. He also observed that rural doctors
prescribe more than doctors based in the towns. Gabe and Williams' study found tranquilizer
prescription rates to be higher in urban than in rural areas.
Patient characteristics include capability to pay, patient- expressed preference for a specific
drug, as well as probability of patient compliance. Denig et al. (1988) found in their empirieal
investigation that when medication is the only treatment option, patient demand may not figure
on _e decision to medicate. The same study by Stolley et al. showed that dissatisfaction among
patients tend to be associated with better prescribing. The study postulated that poorer practices
may have more inappropriate prescribers, but did not f'md the relationship to be statistically
significant.
Moderating factors refer to factors beyond the physician's control. These include availability,
other forms of therapy for the same conditions, and social environment. This study focuses on the
role of the proximate factors in prescribing behavior.
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C. Methodology
A survey was conducted among medical practitioners based in and outside Metro Manila.
Private general practitioners were the main targets of the survey. However, physicians with
specialty i_aining but involved in general practice were also included.
A questionnaire served as the standard instrument. It was designed to elicit information on:
a) Personal background: training particulars, years in current practice, previous
practice, professional affiliations;
b) Conditions of practice related to patients: number of patients per week,
referrals, economic background of patients, impressions on patients, and age
groups catered to;
c) Conditions of practice related to therapeutics: reactions to banning or
restricting certain drug types, typical prescriptions for commonly
encountered outpatient complaints such as diarrhea, fever, sore throat, cough
and colds, and muscle pain; and
d) Perceptions and attitudes pertaining to the _eatment of illnesses, patients'
problems, the drugindustry, drug information, generics and drug policies.
After a pretest, slight changes in the design were made. Initially, the questionnaire, which
took 20 to 30 minutes to accomplish, was administered by an interviewer. However, most of the
respondents preferred the more flexible self-administered method.
An initial attempt to conduct the survey using a two-stage cluster sample method also had to
be abandoned due to geographic limitations, interviewer constraints (a number of them were
medical school students while others were new graduates), and a high refusal rate in the targeted
clusters. Interviewers were then instructed to approach respondents as randomly as possible
within their designated geographic areas.
Cross-tabulations and multiple regressions were used to validate the model.
D. Results
A Profile of Filipino Physicians and Prescriber Characteristics.. Of the 315 questionnaires
reproduced and distributed, 129 or 41 percent responded. Approximately 15.9 percent of the
respondents did not return the self-administered questionnaires while 28.6 percent outrightly
refused. Sixty-two percent (62%) of these refusals came from the provinces. The survey began in
October 1988 and should have ended by December. However, due to its wide coverage (Manila,
Nueva Ecija, Tarlac, Lanao del Notre, and Negros Occidental), as well as the high refusal rates,
the survey was extended to January 1989.
It must be noted that during these survey months, heated debates on the Generics Bill took
place. This may partially explain the high refusal rate, as well as the negative attitude by some of
the respondents approached. Others refused because the interview would take up too much of
their time. The high refusal rate from the provinces raises some concern.
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Table 18 shows the general characteristics of the respondents. Sex distribution is fairly
well-balanced, with a majority of the respondents being married.The respondents are relatively
young; 70 percent is less than 40 years old. A majority (53%) has had some form of specialty
training.Educational qualifications (64%) were obtained from four of the country's best medical
schools. Internship was more dispersed,although 38 percenthad their internship in the four major
schools. At the time of the survey, 89 percent of the respondents indicated affiliation with
medical institutions, mostly hospitals and medical schools.
Classifying their location of practice into urban (Metro Manila) and rural (outside Metro
Manila), a majority of the respondents (57%) were classified as "rural"practitioners.The "rural"
location has to be further qualified though because some "rural"respondents were based in the
towns of the provinces. Most respondentsindicated that their patients belong mostly to the lower
(53%) and middle (37%) income classes. The average number of patients seen per week is 85,
with 22 percent of the respondents indicating a weekly load of more than 100 patients. The
average time spentper patient is 20 minutes, with 34 percent of the respondents indicating 2 to 10
minutes average time spent perpatient.
Seventy-eight percent (78%) of the respondents indicated giving prescriptions in 60 percent
or more of patient visits while only 14 percent did so in 40 percent or less of patient visits. In 40
percent or less of telephone consultations, 77 percent of the respondents indicated giving
prescriptions while 5 percent did so in 60 percent or more of telephone consultations. Not too
many referrals are made from one doctor to another, with 91 percent of the respondents referring
40 percent or less of their patients to their colleagues. Fifty-four percent (54%) indicated
receiving new patient referrals in 40 percent or less of total patients in an average month (Table
19).
Most physicians seem to be satisfied with their patients, with 56-77 percent of the
respondents saying that patient attitudes pose little or no problem in their practice. The attitudes
enumerated include: patients not following advise, accepting only what they want to hear,
demanding inappropriate services and treatment, docile, inquisitive, not wanting drugs they are
not familiar with, and wanting more expensive drugs.
A larger percentage (66%) of the respondents consider that the patient's capability to pay
comprise 50 percent or more of their decision in prescribing drugs. Only 12 percent of them think
that the patient's capability to pay comprise less than 20 percent of their decision in prescribing
drugs.
Table 20 presents the prescribing patterns of the respondents regarding symptoms of diarrhea,
fever, sore throat, cough and colds, and muscle pain. Most respondents (79-95%) indicated
prescribing drugs (mostly brand names) for these symptoms. An estimated 12-37 percent Of the
respondents stated they do not indicate the generic name when prescribing while 8-13 percent
stated they give only generic names.
Presented in Figure 5 are the categories of drug products frequently prescribed by the
respondents to patients suffering from diarrhea. Anti-motility agents account for 41.6 percent of
all drug products prescribed while antibiotics account for 32.3 percent. Only 16.8 percent is
accounted for by oral rehydration solutions. It is worth noting that 6.2 percent of the drug
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Table 18: General Characteristics of Physlcia_.Respondents
Sex Male 65
Female 64
Civil status Single 38
Married 90
Sep/Wid 2
Age group <30 33
30-39 57
40-49 23
50+ 17
Type of practice Gen Med 60
Surg Sp 27
Intnl Mad 19
P@dia 18
Others 6
Medical schools UP,UST.UE.I_U 83
Others 46
Internship UP,UST.US.FEU 49
Others _la 38
Outside MMla 42
Medical institution Affiliated 115
Not affiliated 15
Address of practice Urban 55
Rural 74
Social Status of Lower 69
Patients Middle class 48
Upper 2
Unclear arts ii
Number of patients Average 85 patients
per week S.D. 86
0-50 68 respondents
50-100 33
I00+ 28
Ave. time spent Average 20.6 mlns
per patient S.D. 36.2
2-10 mine 44 respondents
11-20 58
21+ 27
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Table 19: Patient Referrals and Prescriptions
Percent of patients <20% 20-39_, 40-69% 60-80% >80 No ans
New Referrals 26 44 27 17 8 8
_ave. month)
Refer to colleag_es 81 37 3 4 2 3
%_vislts w/ prescriptions
I0 8 9 29 72 2
% tel. consult given
prescriptions 83 17 3 4 3 20
Table 20: Prescribing Behavior foP.Various Symptoms
Symptom Total # # Physicians #not ind # ind
Respndts PrescDrugs generic gen only
Diarrhea 109 83.8% 36.7% 8.3%
Fever 124 95.4 12.1 12.9
Sore Throat 108 83.1 23.1 14.8
Cough-cold 113 88.9 35.4 16.8
Muscle Pain 103 79.2 35.9 12.6
........ ::::::::::::::::::::: ._
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Figure 5
Drug Products Usually Prescribed, Diarrhea
Anti-motility g4: 41%
!}2i!i!i:.
iiii:i);)i Anti-amoebic 8:4.96
.......,.,.,
:_:::iiii;_: Ohloram-Strep 14: 6%
Antibiotic8 73:32 _
Oral Rehyd'Soln 38: 17_
Figure6
•Drug ProductsUsuallyPrescribed,Fever
Paraoetamol
217: g2%
Others
19: 8%
3products prescribed consist of dangerous irrational drug combinations
(chloramphenicol-streptomycin).
For fever, an overwhelming 95.2 percent of drug products prescribed consist of paracetamol
as the single active ingredient. A very small proportion consist of aspirin (1.8%), amoxiciUin
(1.8%), chloramphenicol (0.4%), dipyrone (0.4%), and lagundi (0.4%), a herbal preparation
(Figure6).
In Figm'¢ 7, sore throat prescriptions comprise mostly (69.8%) of antibiotic prescriptions,
mainly ampicillin (30.2%) and erythromycin (24.2%). Penicillin, the drug of choice ff ever an
antibiotic is to be given to relieve sore throat, accounts for only 4.4 percent. Antiseptic lozenges
account for 23.6 percent, and cough-cold preparations, 3.8 percent.
Two major product classifications are predominantly prescribed for cough and colds: cough
and cold preparations (45%) and mucolytics (42%) (Figure 8).
For muscular pain, 54 percent of the drugs prescribed consist of NSAIDS, mainly naproxen,
mcfenamic acid, and diclofenac. Centrally acting muscle relaxants (of doubtful efficacy)
combined with analgesic (usually paracetamol) account for 20.6 percent. Single preparations of
paracetamol and aspirin (usually the rational choice ff drug therapy is indicated) account for only
5.3 percent. Dangerous pharmaceutical products (no longer used in many countries because of
high index of risk over benefi0 containing butazone or glafenine account for 10.1 percent and 8.5
percent, respectively. Another 1.6 percent is accounted for by vitamins and tranquilizers (Figure
9).
With respect to sources of drug information, the most frequent references indicated by the
respondents are the Philippine Index of Medical Specialties (PIMS), books, journals, drug sample
literature and seminars (Table 21). The PIMS is an index of drug products sold in the Philippines
mostly by multinational drug companies and is prepared by the companies themselves.
Table 22 summarizes the respondents' answers to selected statements that might reflect their
personal attitude and awareness of drug-related issues. Responses are on a Scale of 1- 5,
corresponding to the following response options: strongly disagree (1), disagree (2), neither (3),
agree (4), and strongly agree (5).
From their responses can be gleaned a profile of moderation. The areas where strong
agreement was voiced out are in the following: that the government should take an active role in
developing an indigenous pharmaceutical industry, that there are too many drugs in the market
for the same indications, that adverse drug reactions are a serious concern, and that there is a need
to consider the patient's capability to pay for drugs in prescribing.
Strong disagreement was expressed against telling patients as little as possibly necessary for
treatment. It is interesting to note though, that there seems to be no opinion on such statements
asi brand names guarantee quality, detailmen are sources of information, and to prescribe generic
drugs is reasonable. There are a few inconsistent responses, especially in relation to the attributes
of drug companies.
The distribution of physicians' responses to policy formation regarding some problem drugs
is summarized in Table 23. They are sources of concern since most of these drugs are said to
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Figure 7
Drug Products Usually Prescribed, Sore Throat
Amplcllllns 55: 30%
Erythromyolns 44; 24%
Penicillin 8: 4% Others 18: 10%
Other AntlBIo 14: 8%
.Lozenges 43: 24% .
Figure 8
Drug Products Usually Prescribed, Cough and Colds
Cough Cold Prep 97: 45%
Others 11: 5%
Gualfenesln 8; 4%
_$,_,_.. --_ Bronohodllatrs 9: 4%Mucolytlcs g2: 42%
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Figure 9
Drug Products UsuallY Prescribed, Muscle Pain
NSAIDS 102: 54%
Other3 3: 2%
'_ Glafenlne 16:896
Muscle Relaxt8 39 21% Butazones 19', 1096
Paracetamol 10: 5%
Figure 10
Health Care Expenditures (1985)
t (us$130.9)
26,1%
Private73,9%(US$564}
BaSIc $ource:Intercare (lg87)
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Table 21: Sources of D_g Information
Never Almost Few Frequent
" Never Times Total
Source of Ik_IgInfo
a. Detailmen 23 24 51 26 124
b. Journal articles 4 5 59 57 125
c. Books 3 2 48 72 ]25
d. Journal ads 8 18 56 32 114
e. Pharmacist 61 34 21 5 121
f. PIMS 5 3 40 78 126
g. PDR 17 19 50 35 121
h. Seminars 2 I0 70 43 125
i. Drug sample lit 6 14 56 50 126
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Table 22: Responses to drxlg-relatedissues and policy statements
Mean SD
I. Respect of fellow MDs more important
than admiration of other people in
the community 3.07 1.44
2. Best to tell patients as little about
illness as necessary for treatment 1.81 1.19
3. Technical skill more important than
dealing With patient's psycho-
social problems 2.48 1.21
4. Treatment to cover most eventualities
better than individualized treatment 2.38 1.26
5. Doctor's time better spent treating
those actually sick than trying to
prevent disease 2.24 1..40
6. Substantial portion of patient's
complaints are psychological 2.74 1.38
7. Important to consider patient's ability
topay for drugs 3.73 1.26
8. Brand names guarantee quality 2.99 1.46
9. Gov't should take active role in deve-
loping indigenous pharmaceutical
industry 4.28 1.09
lO.Gov't has capacity to regulate intro
of new drugs in the market 3.41 1.55
ll.Too many drugs in the market for the
same indlcatione 4.24 1.12
12.Reasonable to prescribe generic
drx_gs 2.97 1.51
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Table 22 _continued)
Mean. SD
13. Profits of Drug companies
commensurate to their contribu-
tions to drug'reeearch and devt. 2.91 1.47
14. Drug promotion and advertising
indispensable to medical practice 2.91 1.89
15. Drug companies generally exploit
3rd world countries 3.35 1.38
16. Nat'l Drug Policy will reduce
income of doctors 2.25 i.II
17. a. Detailmen mention 81de effects
of drug promoted 2.6 1.27
b. Claim more uses of drugs than are
justified 3.16 1.47
c. Important sources of dm_g info 2.99 1.47
18. Filipino prescriber warns patient
of side effects 3.43 1.20
19. Graduates for past 5 yrs are more
informed than older ones 2.96 1.34
20. Adverse drug reactions a serious
concern 3.76 1.32
21. Fully aware of Nat'l Drug Policy
contents 3.31 1.33
22. Nat'l Drug Pollcybeneficlalto
Filipino people 3.37 1.31
Response options: strongly disagree (i). disagree (2).
neither (3). agree (4). strongly agree (5).
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Table 23: Responses to Pollcv Stance on Some Problem Drugs
Maintand Slightly Hvly Banned
Without Reetrcd Restrcd
Retrctn Total
a. Dipyrone containing
products 8 41 21 54 124
b. Oral proteolytic
enzymes 22 48 15 40 125
c. Appetite
stimulants 37 56 15 40 148
d. Combinatlon antibio
as antidlarrheals 18 46 30 32 124
e. Cerebral activators 20 47 37 15 119
f. Chloramphenicol 34 69 24 1 128
g. Cough-cold combination 31 57 20 19 127
h. _h_ltivitamin-minerals 86 35 7 0 128
i. High-dose estrogen-
progesterone 13 47 48 15 123
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cause serious disorders, are of doubtful efficacy (especially combination drugs), or are generally
associated with high index of risk over benefit.
Sixty-percent (60%) of the respondents favor the banning or heavy restriction of
dipyrone-containing products and 51 percent expressed the same sentiment with respect to
high-dos_ estrogen- progesterone combinations. In general, however, most of the respondents
favor slight or no restriction for the problem drugs presented.
Determinants of Prescriber Behavior. Cross tabulations on the determinants of the frequency
in which patient visits resulted in a prescription, did not yield any significant results. More than
two-thirds of the respondents chose the same frequency range. This indicates the general trend
toward consultations ending in prescriptions.
Factors that would explain the profile of physicians who prescribe ORS as first choice for the
treatment of diarrhea were tested. The likely relationship on logistic regression was estimated
using the maximum likelihood technique. Results are shown in Table 24. Among the variables
contained in the model, two seemingly inconsistent variables surface as significant predictors.
ORS will likely be the first prescription for diarrhea by physicians whose patients come from the
lower income brackets.
There is a significant negative relationship between a physician's consideration of his
patients' capability to pay and his choice of ORS as treatment for diarrhea. In other words, ORS
is not the first choice of a doctor who considers capability to pay as an important criterion for
prescribing a drug. There may be some difficulty interpreting this. It is possible that "capability to
pay" cutsboth ways. It could either mean that patients are able to afford the medicines
prescribed, or that someone who can pay more should be given the more expensive medicine.
The latter interpretation makes sense in this context, medicines given away for free in most
public health centers. There seems to be some price or income discrimination in
prescribing--some drugs are for the poor while some are for the rich, without regard for
appropriateness of use.
NSAIDS would be the first choice for the relief of muscle pain by a physician who believes
that drug promotion and advertising are indispensable to medical practice. This is most likely the
profile of a physician who relies heavily, if not solely, from drug company sources like
detailmen. NSAIDS, which consist mainly of naproxen, mefenamic acid and dielofenac, yield
more risk than expected benefits. Yet, the other significant predictor for muscle pain prescription
confuses the issue. Findings also show that a doctor who believes that drug company profits are
justified by their contributions to the research and development of drugs, is not likely to prescribe
NSAIDS as first choice for muscle pain. This highlights the ambivalence of Filipino physicians
regarding drug companies.
Highlights and Remarks. An analysis of the specific drug products prescribed for the
symptoms listed in the questionnaire reveals the following:
1. The prevalent use of anti-motility drugs and antibiotics for diarrhea
appear to be unnecessary. Their use in non-specific diarrhea, the most
commonly encountered symptom in general practice clinics, is contrary to
universally accepted principles of pharmacology and medicine. On the other
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Table 24: Logistic Regression Results on
Likelihood that Physician will Prescribe
Oral Rehydratlon Salt for Diarrhea:
Prescribe NSAIDS for Muscle Pain
as Dependent Variables
Variables ORS NSAIDS
Intercept .615 -0.341
(2.884) (2.461)
Age O.018 -0.003
(0.028) (0.0251
Sex O. 540 O. 692
(0.605) (0.514_
Location of practice O.394 -0.199
(0.654) (0.573)
Specialist training -0.981 -0.802
(0.644) (0.523)
Member: Ned Society -0.451 0.512
(0.891) (0.788)
Affil: Mad Institute -0.758 -0.216
(0.667) ( O. 528)
Patient load -0.000 -0.003
(0.004) (0.004)
Ave. time spent/Patient 0.035 -0.026
(0.032) (0.027)
Income class/Patient 0.802 0.031
(0.447)_ (0.293)
Index of patient satisfactionO. 484 O. 283
(O.889 ) (0.700 )
Detailmen as sources of info 0.185 -0.026
(0.275) (0..238)
Ave. no. of visits of Dtlmen-O.178 0.004
(0.177) (0.158)
BeIlevee:
Drug promotion indispensable
to medical practice -0.143 O.461
(0.279) (0.253)**
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Table 24 (continued)
Variables ORS NSAIDS
Drug industry profits
commensurate to R & D 0.254 -0.479
_0.2861 (0.2321.*
Important to consider
patients" capability to pay-0.581 0.181
(0.284)** (0.2191
Gov't has capacity to
regulate new drugs in 0.235 -0.065
market (0.2001 (0.164)
Aware of contents of Nat'l
Drug Policy (NDPI -0.070 -0.201
(0.2601 (0.2131
NDPwlII benefit Filipino
people -0.421 0.166
(0.2881 (0.2371
Figures in parenthesis are standard errors.
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hand, oral rehydration salts, the treatment of choice for diarrhea, is sparingly
prescribeA.
Dangerous pharmaceutical Products without valid justification for use in
diarrhea are being prescribed in small but significant proportion. This can
trigger a higher rate of patient consumption since patients tend to repeat and
recommend to others the consumption of a previously prescribed drug (Hardon
1988).
2. Paracetamol, although the drug of choice for fever, is also being
prescribed unnecessarily. Most cases of fever on an outpatient basis would not
need any antipyretie drug.
3. Antibiotics, including chlorarnphenicol and dipyrone, are still being
prescribed for fever. Dipyrone is banned in many countries because of serious
toxicity. Antibiotics, especially chloramphenicol, should not be given blindly
for fever because of unacceptable risk-to-benefit ratio. They should only be
given if intended for a specific infection causing the fever.
4. Antibiotics are prescribed unnecessarily for sore throat. The wrong
antibiotic is usually being prescribed, even in cases where antibiotic use is
justified. Antiseptic lozenges are being prescribed unnecessarily. Cough-cold
preparations also get into prescription, quite an irrational option for the
treatment of sore throat.
5. Fixed-dose cough-cold preparations are prescribed most commonly for
cough and colds. Next are the mucolytic preparations, products of questionable
necessity and efficacy for cough and colds. Although in small proportions,
there can still be found prescriptions of doubtful efficacy in bronchodilators,
antibiotics, enzymes and vitamins.
6. The use of NSAIDS as first choice for muscle pain is questionable since
risks outweigh expected benefits. Even relatively safer analgesics like
paracetamol and aspirin, which account for a very small proportion of
prescriptions for muscle pain, are seldom necessary. Also of doubtful efficacy
are combinations containing muscle relaxants. A significant proportion of the
prescriptions consists of dangerous drugs banned in other countries. Vitamins
and tranquilizers are also prescribed.
One patient-related factor, his capability to pay, figures significantly in the prescription for a
more appropriate first choice. This factor gathered the second strongest agreement among
physicians. Since a majority of the respondents' patients come from lower to middle income
classes, considering their capability to pay may be more of a necessity. However, the tendency to
segment drug products (that some drugs are for the rich and some are for the poor) is without due
regard to the appropriateness of the prescription. Moreover, the need for symptomatic relief may
also be due to the doctors' desire to impress rich patients. Cost-consciousness produces a reverse
effect of market segmentation. Its policy implications will be explored in the final chapter.
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Quite irrational drug choices are sensitive to the relationship or attitude of physicians to drug
companies. Although links have not been clearly established, they came out to be significant,
albeit ambivalent in the case of a questionable first choice for treatment of muscle pains. The
influence of drug companies has been all-pervasive among practitioners, probably creating
divisions among groups and ambiguousness within themselves. This largely springs from the
relative dependence of practitioners to drug companies for an important aspect of
practice--information.
The approach to household utilization of drugs from the perspective of prescriber behavior
highlights the need for rationality in the use of pharmaceuticals. The pressure for behavioral
change seems toTall heaviest on the prescriber. However, the prescriber is but a "customer"
protected and managed by producers (Leifman-Keil). This points to the need to depersonalize the
relationship between prescribers and producers (drug companies). The role of the drug industry in
the current pattern of medicalization has been much written about. What remains is for political
will and action to effect some changes.
IV. PHARMACEUTICAL USE AND SUPPLY: A MACRO OVERVIEW
This chapter views drug utilization from the broader perspective of the Philippine
pharmaceutical market. The first part examines data sources utilized in this review while the
second examines drug expenditures in the country vis-a-vis total health care expenditures (HCE).
The third part describes the country's drug supply system and the last explores policy issues
concerning drug pricing, local drug manufacturing and government procurement of
pharmaceuticals.
A. Data sources
A number of studies have looked into the pharmaceutical industry in the country. Foremost of
these is the 1980 study by Kintanar (now an Assistant Secretary of Health) for a UN body. The
study provides a comprehensive accounting of the drug requirements in the Philippines and
explores the production capacity of drug companies in 1980. The study is fortunate to have gained
access to recent estimates of Kintanar on drug requirements and consumption for the United
Nations Industrial Development Organization CLINIDO) and the DOH's project on the
development of the Philippine pharmaceutical industry.
A more recent work by Intereare 0987) is the often-cited study on health care expenditures
and financing in the country. This work has been published as part of the proceedings of the
Regional Seminar on Health Care Financingsponsored by the Asian Development Bank,
Economic Development Institute (World Bank) and the East-West Center.
The Philippine drug industry has also been the subject of a comprehensive master's thesis by
Gabunada (1983). The study records the growth trends and future prospects of the industry. It is
valuable in examining trends in the manufacturing industry from the postwar period until 1981, as
well as in mapping out its growth prospects and problems. Gabunada has also updated certain
aspects of his work through a "factbook" on the pharmaceutical industry.
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A studyconductedby theNationalCensusand StatisticsOfficein1979bringstogether
statisticsfromofficialsurveyson drugmanufacturingandtheretailtrade.However,thcpresent
NationalStatisticsOffice0NSO) canprovideverylittledataondrugconsumptionbecauseofthe
changinglevelsofaggregation.Drugswerenotevcnincludedaspartoftheconsumptionbasket
uscdinthecomputationoftheConsumerPriceIndcx.Intcrmsof'pharmaceuticaltrade,theNSO
remainsto be the main sourceof statisticson importsand exportsof medicinesand
pharmaceuticalsupplies.
OthersourccsofdataincludetheIMS, a marketingrcscarchagcncywithan international
networkspecializingpharmaceuticalintelligence.Theyregularlycome outwithdrugsalesdata
andprojections.The DOH's Task Forceon Pharmaccuticalsalsoprovidesdataculledfrom
variousources.
B. Patterns of Pharmaceutical and Health Care Expenditures
How much do Filipinos spend for pharmaceuticals? The annual per capita expenditure for
drugs in 1987 was P162.00 ($7.70). Table 25 shows that this figure is a 34.5 percent
improvement over 1985 figures in real terms. A big rise in per capita consumption appears to
have been felt between 1980 and 1985. In real terms, 1987 figures are 82 percent of 1975 figures.
The table reflect sales figures generatedmostly through drugstores or pharmacies and, thus, does
not take into account expenditures for medicines through informal or illegal channels. No data is
available on the extent of drug consumption through irregular channels,
The real decline in per capita expenditures on drugs reflects the decline in overall health care
spending in the country. The Philippine health care system is predominantly private. An Intercare
study (1987) shows that of the total HCE of US$762.9 million spent in 1985, 73.9 percent was
accounted for by the private sector and 26.1 percent by the government (Figure 10). Private
spending which comes mainly from household budgets, comprised 49.5 percent of private HCE.
The same study notes that over a five-year period, private spending for health care has steadily
increased from 65.8 percent in 1981 to almost 75 percent in 1985, growing by an average of 5
percent. In contrast, public spending for health care for the same period shrunk by 35 percent.
Overall HCE in 1985 was only 91 percent of 1981 levels.
The declining patterns in health care expenditures may be due to the economic crisis which
hit the country from 1983 to 1985, during which the peso was devalued against the dollar and
foreign exchange restrictions and tight money supply prevailed.
In terms of private spending for health care, Figure 11 indicates that the bulk of expenditures
in 1985 went to professional charges (34.4%), drug purchases (32.9%), and hospital fees (26.6%).
Drug expenditures dropped by 5.7 percent from 1971 to 1985. Provider fees have remained stable
for the past two decades. It is interesting to note that of the total expenditures, the shares of
hospital charges and drugs have been moving in opposite directions. Hospital charges increased
between 1965 and 1971 and decreased in 1985. Meanwhile, drug expenditures decreased between
1965 and 1971, then increased in 1985. This trend merely reflects movement in the prices of the
two (NEDA 1986). Later on, drug price indices outpaced those of medical services.
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Figure 11
Distributionof PrivateHealth Care Expenditures
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Figure 12
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Table 25: Per Capita Sales of Medielnee/Drugs
Year Current Values Real Values
(pesos) (1978 pesos)
1975 41.33 53.33
1980 48.85 35.17
1985 115.17 32.66
1987 162.O0 43.94
Source: RP-UNIDO Papers.
Table 26: Government Allocations and Drug Expenditures
Year Allocation % of Total Expenditures
{in P million_ DOH Budget (in P million_
1986 12"/ 3_34 80.4
1987 287 7.72 336.4
1988 300 5.6
1989 40O
Source: Department of Health. Logistics & Procurement Office
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In terms of public spending for health care, the bulk of expenditures went to curative care.
The Intercare study shows that between 1981 and 1985, 57 percent of the total amount spent by
the government went to Curative care (i.e., hospitals) compared to the 33.3 percent that went to
preventive care. The share of preventive care has declined from 37 percent in 1982 to 28 percent
in 1985, while the share of curative care has risen from 54 percent in 1982 to 63 percent in 1985.
Public spending in health came from local and national tax revenues (87 percent). During the
same year, user charges or operating income accounted for only 4.9 percent of government fund
sources while foreign loans and grants accounted for 8 percent. User charges comprised 23.2
percent. The category "others," which did not show any aggregation, accounted for 34 percent of
total HCE spending. Compulsory insurance benefits consisted 4 percent of total HCE while
foreign loans and grants consisted only 1.8 percent of total HCE.
Table 26 shows the value of allocations and drug expenditures of the DOH. In 1988,
allocations for drugs comprised 5.6 percent of DOH appropriations from the national budget.
Compared to previous years, government allocations for drugs declined as a proportion of DOH
expenditures. Other program budgets had to fund drug expenditures which exceeded allocations.
The adequacy of these drug expenditures may be gleaned from consumption/requirement
ratios. Kintanar (1987) provided estimates of consumption levels and requirements based on the
country's disease incidence, current standard therapy and price levels. In Figure 12, consumption
levels in 1987 represent merely 18 percent of total drug requirements for that year. Excess
consumption is noted for certain drug types, notably drugs for ailments of the sensory organs,
skin, sex hormones, and the genito-urinary area. Inadequate consumption is noted for drugs for
parasitosis, blood-related, cardiovascular, and systemic hormone disorders. Between 1985 and
1987, inadequate consumption persisted for the same types of drugs. In one case, dermatological
requirements declined but consumption increased.
The extent to which these estimates are effects of volume changes rather than price is
uncertain. At best, the consumption- requirement ratios indicate the nature of therapies sought in
the market as a result of self-medication practices and/or inadequate diagnoses. Shortfalls in
consumption also indicate the role of other factors that affect consumption, for instance,
capability to pay and the value placed on health.
Unpublished tables of •the 1985 Family Income and Expenditures Survey (FIES) show that of
the total number of families surveyed, only 89 percent reported expenditures for medical care.
Health care expenses comprised only 2.1 percent of total family expenditures. The proportion of
families reporting such expenditures increased directly with income. Ninety-four percent (94%)
of the top-earning families reported spending approximately 2.5 percent of their income on
mendical care. Meanwhile, only 67 percent of the lowest income-earning families reported
spending 1.4percent of their income on medical care. Such expenses took up a smaller proportion
of family income compared to those spent for alcoholic beverages and tobacco. This is true
especially among the three lowest income classes.
C. Pharmaceutical Supply and Distribution Systems
In December 1986, the Bureau of Food and Drugs of the DOH registered some 12,153 drug
products: 10,048 (82.6%) are in brand names, the rest in generics. Belonging to appoximately 40
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therapeutic classes, these products correspond to 7,500 drugs. The total number of drugs
registered at that time exceeded those registered the previous year by 94.6 percent. For each
product class, there exists numerous brands under various formulations. Table 27 presents an
estimate of the number of brands and generics proliferating for selected product types.
Consumers obtain pharmaceuticals either by buying from retail drugstores or by asking from
government health centers where these are given free-of-charge. Drug manufacturers utilize
either of two distribution networks: direct to retail outlets or through distributors. Fifty-three
percent (53%) of the distribution work is done by distributors while 47 percent is done by the
drug manufacturers themselves. Figure 13 shows the distribution flow from manufacturers to
end-users.
Distribution companies are large establishments responsible for the distribution and
promotion of the various lines of drug product. Wholesale/retail outlets and hospital pharmacies
are serviced by distribution companies, which have vast networks of depots, detailmen, and
salesmen. One distributor may handle competing products. A drug industry study notes that
distribution fees vary from 12-15 percent of product sales, depending on the type of product
handled.
Latest figures from the Bureau of Food and Drugs show that there are 1,034 drug departments
(importers/exporters as well as distributors and wholesalers of finished products and raw
materials) and more than 9,000 drugstores and pharmacies. The IMS, however, has on record
only 5,000 pharmacies (Businessworld 1988). A status report of the Drug Association of the
Philippines (DAP) shows that there were more than 8,585 drugstores, 882 hospital pharmacies,
and 325 rural pharmacies (botica sa barangay) scattered throughout the country in 1986. In 1985,
89.5 percent of total market sales were conducted through retail drugstores, while 10.5 percent
were made through hospital pharmacies. Of the pharmacy sales, 73.3 percent were made in
private hospitals and 26.7 percent were sold through government hospitals.
Across the country, the drug distribution system is fairly advanced, albeit geographically
concentrated in rich centers. Metro Manila is the biggest market for drugs in the country, with
shares ranging from 44.2 percent in 1975 to 48.8 percent in 1985. The region is occupied by 12
percent of the country's population. In 1985, it contributed nearly half of the national output.
As in other less developed countries, pharmacies or retail drugstores in the Philippines appear
to be important sources of health care by virtue of their relative accessibility. They are run like
any commercial establishment on a profit basis and employ salespersons who may not have any
training in drug dispensing. These salespersons are often approached for suggestions on the best
drug therapy. Some get commissions from the sale of certain product lines. Drugstore owners
themselves are provided with all kinds of incentives or discounts by drug distributors. It is quite
common to see drugstore signs bearing the name of the drug company sponsor. Discounts may be
given not only on total sales volumes but also on a per unit basis. This means that for every unit
sold, a bonus of one or more units will be given free-of-charge in the next order. This is not
unlike the "push therapy" cited by Haak (1987) from other authors.
Over-the-counter drugs are brisk business. Prescription drugs are easily obtained without
prescription. Pharmacy law requires the presence of trained pharmacists in these establishments.
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Table 27: NL1.berof Brands and Generics
Under Selected Product Types, 1986
Type Formulation No. of Brands Generics
Paracetamol single 244 202
Ampicillln fixed dose 113
combination
Penicillin single 209 195
Penicillin vk single 272 115
diphehydranine single 7 2
fixed dose 23
--- data not avallable
Basic soLu_ceof data: Bureau of Food and Drugs. DOH
Source: DOH Task Force on Pharmaceuticals
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In the Philippines, the practice is to prominently display the "diploma" of the owner, who may be
a pharmacist, along with the license to operate (if there is any). Most large supermarkets have a
drug section, while major drug retailers also carry grocery lines.
In the public sector, drugs are distributed through government hospitals, health centers and
rural pharmacies. The public distribution system is shown in Figure 14. Of the total drug sales in
1985, only 4 percent were sold to government (Intercare 1987).
About 85 percent of drugs procured locally are distributed equally among the 1,991 rural
health units (RHU) spread across the country. Fifteen percent (15%) are held as reserve stocks for
national and regional levels. The provincial health officers are responsible for distributing the
medicines and supplies to municipalities, which in turn distribute them to the RHUs. Medicines
prescribed to patients by RHU medical personnel are given for free. A constant concern,
however, is the ability of the government to sustain such an operation given chronic budget
shortages.
D. Policy Issues and Concerns
Drug Pricing. Drug prices have outpaced prices of other basic commodities, except for the
periods 1980-1982 and 1984-1985. It is interesting to note that from 1984 to 1985, when the
country experienced its worst economic crisis, drug companies managed to contain the rise in
drug prices. Yet, at the start of the economic recovery in 1986 and 1987, with inflation at 1 and 4
percent, respectively, drug prices soared faster than consumer prices (Table 28).
The price structure of the drug industry is determined in part by the nature of the market of
the type of drug (Figure 15). The price movement of over-the-counter or proprietary drugs is
parallel to those of other commodities which consumers buy using their disposable incomes. The
market for ethical or prescribed drugs would be more sensitive to correlates of prescriber
behavior. The rise in prices varied across the years for both types of markets. In Figure 15, a
two-year pattern in the movement of drug prices in these markets can be observed. Prices of
over-the-counter drugs rose faster during the best (1980-1981) and the worst years (1984-1985),
economically speaking. On the other hand, prices of prescribed drugs rose faster during the
slowdown (1982-1983) and the recovery periods (1986-1987).
These price increases for the two types of market may be attributed to demand and supply
factors, as well as new product developments in the market, particularly prescriber medicines.
Patterns in the OTC market may. be interpreted in a straightforward manner. Although the
relationship is by no means perfect, a rise in per capita income (measure of economic status) may
improve health States and enhance the people's capability to pay for drug therapy and
maintenance. Under low per capita income, health conditions may worsen and people may turn to
self- medication instead of obtaining prescriptionf for medicines through formal consultations
with physicians. That both economic recovery and slowdown may increase demand, hence prices
for prescribed drugs, defies easy answers. For the prescription drug market, this may be the case
of s'applyconsiderations outweighing demand conditions.
An analysis of the financial statements of some 39 firms in the drug industry shows that mark
up prices vary depending upon the drug fn'm's nationality. Mark up prices are defined as the
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Figure 15
Movement of Prices in Ethical and OTC Drugs
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Table 28: Drug Prices vs. consider Prices. 1980-1987
(growth rate in percent)
Price 1980 1981 1982 1983 1984 1985 1988 1987
Index Type
Consu-
mer 18.2 13.1 i0.2 9.9 50.3 23.0 .9 3.8
Drugs 11.6 8.4 7.6 29.0 39.2 9.0 13.2 8.2
OTC 12.6 9.6 6.6 20.0 48.7 12.5 11.2 7.8
Ethical
11.4 8.0 7.8 30.8 37.6 8.3 13.7 8.0
Basic source of data: IMS, Philippines, 1988
Ref: Cu.vegkenget. al. 1988.
Table 29: Breakdown of Mark-ups: [bmestic Vs. Foreign Firms
Type.of Firm OpExp _Profits Taxes
Domestic Firms 87% 8% 4%
Foreign Firms 53% 29% 16%
Fi_ires are averages for the 1983-1986 period.
Calculated from compan.vfinancial statements from SEC.
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percentage increase a firm imposes on top of what it has initially paid for its products. The
average markup for domestic firms is 43 percent while the average markup for foreign firms is
132 percent. On the average, foreign firms charge three times more than domestic firms.
Operating expenses account for roughly 66 percent of markup prices, profits, 18 percent and
taxes, 10 percent. A significant proportion of the amount that goes to operating costs is utilized
not in manufacturing but in such aspects of sales as promotions and distribution (Table 29).
There is a significant relationship between a drug firm's nationality and the markup
components. Operating expenses account for 87 percent of markup prices of domestic firms and
53 percent of those of foreign firms. Profits account for only 8 percent of the markups made by
domestic firms and 29 percent of those made by foreign firms. Taxes comprise 4 percent of the
markups imposed by local companies and 16 percent of those imposed by foreign firms.
The average markup charged by domestic firms appears to be less than one third of those
charged by foreign firms. Almost 90 percent of the much smaller markup of domestic firms is go
to operating expenses, while almost half of the much larger markup of foreign firms go to profits
and taxes. This indicates that domestic firms are far more efficient in delivering drugs and
medicines to the local market than foreign firms.
Leading in sales is a Filipino corporation which has a market share of 21.28 percent. In
general, multinational firms control 60 percent of industry sales. Among them, individual shares
range from less than 1 percent to a high of 5.4 percent.
The generics drug program is expected to alter current pricing practices due to stiff
competition in the market. It is generally acknowledged that drugs sold as generics are five times
less expensive than branded products (Foster 1989). A case in point for the Philippines is that of
paracetamol which costs only 30 centavos in 1986 prices. A top-of-the line brand of the same
dosage form costs P1.80 (Tan 1986, cited in Manlayaon 1988). The Generics Law is expected to
affect not only prices but the overall way of doing business, drug utilization and prescription.
Local Production of Drugs. A 1979 classification of the level of development of the
pharmarceutical industry in Third World countries (Wang'ombe and Mwabu 1987), clasifies the
Philippines under group 3 (out of 5 groups). This category is characterized as having the
potential to process a broad range of bulk drugs into dosage forms and manufacture simple bulk
drugs from intermediates. This is supported by an OECD study (cited in Tucker 1984) which
shows that 91 percent of local drug supplies are processed and formulated domestically and only
9 percent are imported.
In local production, 90 percent of all active materials and auxiliaries used are imported. Only
one local company, established in 1981, is engaged in the manufacture of raw materials for
antibiotics (e.g., ampicillin, amoxycillin, and cloxacillin). These active substances are then sold
to other drug manufacturers or are exported. For a time, the firm enjoyed a protected status from
the state which prohibited the importation of these substances.
The Bureau of Food and Drugs distinguishes between drug laboratories and drug
departments. Drug laboratories refer to manufacturers while drug departments are establishments
engaged in the distribution/wholesale as well as the import/export of finished products and raw
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materials. The LMS lists 524 companies active in the pharmaceutical business as manufacturers or
importers. There are 32 large-scale manufacturing laboratories. Two of these, Interphil and
Drugmakers, are exclusive contract manufacturers for registered manufacturing companies
without laboratories. Four others produce their own product lines aside from being contract
manufacturers.
In terms of trade, pharmaceutical imports comprised 1.12 percent of total imports, while drug
exports averaged only 0.12 percent of total exports. The country's drug import bill reached P103
million in 1987. Import expenditures on drugs manifested an annual growth rate of 8.3 percent.
Vitamins, vitamin preparations, and penicillin, streptomycin, and antibiotics comprise the biggest
subgroups imported. A Significant decline in the import of antibiotics was observed after 1982
dt_e to the establishment of Chemfields and the protection it enjoys. The company imports
medicinal preparations and raw materials from more than 30 countries, manily from the United
States, Switzerland, Germany, and the United Kingdom. It exports vitamins and similar
preparations which comprised one-fifth of total drug exports. In 1987, major export markets were
Hongkong, Taiwan, and Malaysia.
The absence of a petrochemical manufacturing capacity in the country prevents the
development of a viable chemical industry. Studies commissioned by the UNIDO, however,
pinpointed that upstream integration is still possible due to the presence of raw materials, mainly
of agricultural origin (sugar, cassava, corn starch, and medicinal plants), such raw materials could
be used as critical inputs in the production of pharmacologically active chemicals using
biotechnology. At present, the government operates three herbal processing plants which produce
four herbal drugs. On a pilot basis, there are attempts to establish a multipurpose fermentation
plant for antibiotics. Still on a pre- feasibility stage is a project for the establishment of a
penicillin and 6- Aminopencillanic acid production plant.
All these are in line with the government's thrust to attain self-sufficiency in pharmaceutical.
This may be a slow process considering the shortage of fund sources, but the experience of
Chenffields shows that upstream integration in pharmaceutical development is possible in the
country. However, current experience in herbal drug manufacture shows that projected
production costs may exceed the selling price (Gamboa in Manlayaon 1988). It may be
worthwhile to echo Foster (1989) at this stage when she warns that most African attempts in local
self-sufficiency in pharmaceutical production have had mixed results. She strongly argues that:
The objective of domestic drug production should be to get good quality,
therapeutically useful drugs to people who need them at prices they can afford. It
should not be to enhance national prestige, or to achieve self-sufficiency, or to
generate employment, although all of those things might be desirable. If domestic
production can provide good quality, low-price drugs, all to the good. If not, it is
probably better to buy drugs abroad as cheaply as possible, package them
locally--and choose another sector to lead industrial development. (p.15)
Public Procurement of Drugs. The DOH procurement system has been the subject of so much
controversy due to certain practices durng the earlier regime. For instance, during the Marcos
administation, a local drug company was able to gain executive fiat to be the sole supplier of
government medicine requirements. But with the change in government, procurement has been
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subject to fair bidding procedures, a system which netted some 30 percent savings on the part of
the DOH.
On the planning stage at the DOH is a distribution system based on the size of the population.
The DOH is also seriously considering proposals which call for one formulary per region rather
than having one national formulary. This proposal intends to make drug purchases more relevant
to the region's health needs. At the regional level, there is some discretion on the purchase of
drugs in excess of regional allotments from the national office.
One of the pillars of the National Drug Policy is the targetted procurement of government
medicine supplies. This recognizes the critical role that adequate and timely supply of
pharmaceutical supplies (including vaccines) play in establishing and restoring the people's
confidence in the public health system. One of the approved steps is to allow the government, in
view of a shortage, to directly import raw materials and allocate them to local drug companies.
This is a powerful and critical tool in the transition phase of the government's Generics Law
policy. To gain leverage, drug groups have threatened to withhold supply. The provision to
import does not in any way impinge on the private farms' right to import. R may even redirect
current pharmaceutical production to address the shortage problem which normally occurs for
drug types not profitable to market but beneficial to the health needs of the countryside and the
poor.
But the government's procurement system must ensure that public health units have timely
and adequate supplies of pharmaceuticals. As studies have shown, centralized bulk buying is
more efficient than fragmented efforts (WHO 1988). Greater leverage in negotiations among
prospective suppliers can be realized through bulk purchases. Given a stronger purchasing power,
market search can be conducted for the lowest price offers. Countries like Mozambique and
Bangladesh have enjoyed the huge savings their strategy offers. The design of the drug
procurement program must feature a decentralized manner of identifying and forecasting the
country's drag needs. Technical and manpower, even storage, capabilities maynot yet be present.
E. Concluding Remarks
The predominantly private health care system in the country has caused the people not only
demand constraints, given low levels of income, but also ineffective and wasteful use of limited
resources. The problem remains one of making cost-effective decisions along with efforts to
expand resource bases. Options lie toward improving the procurement system for the public
sector, undertaking local production of essential drug substances with the ultimate goal of
providing quality yet affordable medicines and providing a policy climate for the local drug
companies to enable them to flatly compete with foreign counterparts.
V. POLICY DISCUSSIONSAND CONCLUSIONS
This chapter highlights certain issues that arose from previous discussions, particularly within
the context of the National Drug Policy (NDP), recently enacted into law. The main objective of
the NDP is to provide more Filipinos access to critical drugs. Its four areas of concern are:quality
assurance, rational use, self-sufficiency and targeted procurement of drugs by government.
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The immediate link of a drug utilization study with policy is related to the policy objective of
improving rational use. This study has shown several aspects of the problem. First, the relatively
low levels of consumption, either in terms of complaints, consumption-requirement ratios for
critical needs and per capita expenditures. Second, the very meager resources spent on drugs Of
low therapeutic value (cold/cough/stomach remedies and vitamins, among others). And third, the
wasteful consumption of drugs by households which reflects patterns of irrational prescribing.
A program of rational drug use must aim to improve drug selection and utilization on the
basis of efficacy, safety, need and cost.
The determining factors of household behavior are less reIated to socioeconomic variables as
they are to morbidity, health Service supply, and demographic factors. Households have shown
willingness to purchase medicines brought about by morbidity conditions. The nature of
information that patients receive from such formal service units as physicians, health centers, or
drugstores needs to be addressed in the light of purchases of medicines of questionable value.
Self-prescribing largely influenced by 'media and experience with previous prescriptions,
The extent irrational choice made by prescribers is largely a function of drug industry
attributes, especially the doctor's perception of the rote and importance of the drug industry. The
physician's heavy reliance on information provided by drug companies places them in an
ambivalent'position vis-a-vis the industry's shortcomings.
The proliferation Ofdrugs of doubtful efficacy and dangerous drug combinations also merits
action from government. So long as they remain unregulated, they will be prescribed. This calls
for stronger police powers for the regulating and monitoring agency, the Bureau of Food and
Drugs. In addition, vigilance is required among professionals, particularly in monitoring and
reporting adverse drug reaction cases. This can strengthen regulatory powers.
The NDP with generic prescribing as its centerpiece program, aims to break the monopoly of
knowledge vested in the physician and, ultimately, on the drug producers. With its basic thrust of
providing choice to consumers by making them aware of a wide range of products and prices for
the same drug indications, the NDP hopes to encourage physicians to practice more cost-effective
prescribing. One way of making the market more price competitive is by breaking into the
protections provided by brand names. With generic prescribing, the relationship between
physicians and drug companies is expected to weaken or move along more professional lines.
With the NDP, the control over drug purchases goes back to the consumer. However, this
makes consumers more vulnerable to the drug companies as they aggressively change strategies
in the face of generic practice--from influencing physicians to promoting their products directly
to consumers. To counter such promotional practices in the drug industry, the government should
provide alternative and consistent sources of information to the public, as well as prescribers.
Otherwise, nothing much would change. Consumer groups have ,to close ranks with the public to
protect this newfound sovereignty.
Clearly, the rational use of drugs by households and prescribers require behavioral changes
that cannot be achieved overnight. It requires sustained campaigns to inform and educate the
public, as well as health practitioners, on the role and appropriate use of medicine not only within
the health sector but also for overall societal considerations. The starting point of behavioral
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change is information. In the case of the drug market, the informational problem is compounded
by the existence of more than 12,000 brands in the market. While generic prescribing promotes
choice among consumers, there seems to be no provision on how choices can be improved.
Consumers still have to contend with the numerous products in the market, many of which are of
dubious quality and use. The economic benefits of generic labelling and prescribing can be
outweighed by the costs of wrong, wasteful or low quality utilization unless drug production and
distribution are rooted in the actual health needs of the vast majority.
Concern for the cost implications of poor drug selection and procurement has led many
developing countries to adapt an essential drugs program. The improvement of the selection
process in the present context of the NDP necessitates a finn commitment by the government to
put together an essential drugs list (EDL). An EDL would enhance rational choice and drug use
and promote a more systematic procurement, distribution and monitoring system, especially for
the government. This will promote more cost- effective purchases of medicines for households,
as well as for the government. It will also stretch the government budget to make available an
adequate supply of drugs for the basic drug needs of the population, particularly the poor.
The highly private sector orientation of the Philippine pharmaceutical market has rendered
such a list inoperable, even if, to a small extent, it may exist for government procurement
purposes. Given the program's advantages, other countries' experiences show that it has been
undertaken and directed at the primary level (LSHTM and KIT 1989). It forms one of the core
elements of the primary health care approach. International evidence strongly supports such an
approach (WHO 1988).
Alongside behavior and informational issues, the problem of purchasing medicine and quality
monitoring poses a major challenge to the government. But with the support of WHO, UNICEF
and other agencies concerned with improving the health situations of nations, opportunities to
make the present situation better exist. Bulk purchases have saved governments precious foreign
exchange. The governments of countries which have adopted the EDL continue to educate their
health workers on its effective use. Assistanceat estimating drug needs is a prerequisite to
government planning and procurement. An EDL is determined on the basis of community health
needs and may vary among areas. However, common diseases have fairly standard treatments.
Packaging drugs in these standard forms can greatly assist the curative capacity of primary level
health workers.
A more forward-looking policy addresses the issue of self-sufficiency in the production of
pharmaceuticals. Studies and recommendations made by UNIDO on this aspect have been
utilized in the formulation of the NDP. What is required at present is firm resolve on the part of
the government to pursue the program. The initial costs that may be borne must be weighed
against its long-term benefits.
Meanwhile, drug industry regulations must be reviewed to facilitate a reduction in drug
prices. In all countries of the European community, for example, regulations are imposed on
wholesale and retail price margins (Abel Smith 1983). Rational prescription can also be supported
by limiting sales promotion activities. This can be done either by issuing guidelines as to what
amount can be deducted as costs in the calculation of prices and profits, or by banning the
distribution of samples to doctors and medical facilities.
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A major challenge, too, for the Philippines lies in promoting some form of system in the
private consumption of medicines. Expenditures for drugs largely come from household budgets.
Strategies must be designed on how limited household budgets for drugs can be maximized on
safe and efficacious drugs. One way to do this is through health insurance. The health insurance
system may also be one area where rationality in medicine use can be promoted through a system
of reward and sanctions. But with the weakness of the country's health insurance system, it may
take some time before clear policy directions in this aspect can be seen.
A more promising area is on the community level. Access to essential drugs can be improved
through a cooperative undertaking wherein households contribute to a community fund be used
solely for health purposes. Other countries have their community revolving drug funds. Some
non-government organizations are exploring this area of cooperative endeavor. Its success may
depend on certain prerequisites, such as substantial start-up funds, good management, correct
estimates of drug needs, timely procurement, a "saving" culture, community involvement, and
commitment.
These four issues on behavior, information systems, costs and participation, indicate clear
policy directions that may be undertaken in an integrated manner. A policy menu is presented
below.
Time Policy. Interventions Expected Outcome or Affected Areas
Short-term Strengthening of Lower prices of drugs
generic use
Adoption ofan EDL Cost-effective prescribing
and use of resource
Strengthening of Alternative and objective
information dissemi- sources of drug information
nation capability of
BFAD and medical
institutions
Review of the safety Banning of dangerous drug
of all drugs in combinations and other
the market substances
Development of training Rational use of medicines
modules for health through better information
personnel on generics
and EDL (including
retail stores)
Decentralization of Efficiency in drug procurement
drug needs but effective and distribution
control over procurement
process through bulk
purchases, importation
of essential supplies
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Identification of Community participation and
communities with viable sustainable supply of.
organizations to essential drugs
undertake revolving
drug funds
Review-of drug industry Reduced drug prices and
particularly pricing rational prescribing through
and promotions regulation
Medium-term Strengthening of Information and rational use
medical curricula of medicines
on EDL
Strengthening of Community participation and
community programs adequate supply
Promote EDL through Cost-containment and adequate
financing schemes supply
Long-term Local production of : Self-sufficiency in pharmaceu-
essential active tical production
substances
Clearly, drug utilization issues cannot be separated from overall health care issues. Medicine
forms one of the many inputs for better health. Pharmaceutical planning must form part of the
overall vision for health ,and health care in the country. The challenge has been taken by many
countries. For the present administration, the extent to which it takes up the challenge .will
determine the effectiveness of its health policies.
63
BIBLIOGRAPHY
Abel-Smith,B. Valuefor Money in Health Services. London:Heinemann,1976.
. "Economic Efficiency in Health Care Delivery." International Social
Security Review 2 (1983): 165- 79.
Baiter, M. "Coping with Illness: Choices, Alternatives and Consequences." In Drug
Development and Marketing editedbyR. Helms, 1976.
Barker,C. and Segall, M. Two Papers on Phamaceua'cals in Developing Countries.
Sussex: Instituteof DevelopmentStudies, 1975.
Bureauof IndustryEconomics. "RetailPharmacyin Australia-An Economic Appraisal."
ResearchReportNo. 17, 1985.
Bengson, A. "TheNationalDrugPolicy: RevolutionaryGoals throughReformistMeans"
Solidarity May-June,1988.
Chien,R. Issues in Pharmaceutical Economics. Toronto:D.C. Heathand Co., 1979.
Chudnovsky,D. (ed.) "The Challenge by Domestic Enterprises to the Transnational
Corporations'Domination:A Caseof the ArgentinePharmaceuticalIndustry."World
Development 7 (1979):45-58.
Co, J. and Tan, M. (eds.) Restoring Health Care in the Hands of the People.
Proceedings of Symposia on Health Policy Development sponsored by
BUKAS-HAIN, 1987.
Cuyegkeng,J.et al. "TheNational DrugPolicy: A Cure-AllT"CRC StaffMemos No. 34.
Centerfor Researchand Communication,1988.
Denig, P. et al. "How Physicians Choose Drugs." Social Science and Medicine 27, 12
(1988): 1381-86.
Dowling, H. "How do PracticingPhysicians Use New Drugs?" Journal of the American
MedicalAssociation 185, 4 (1963): n.p.
Drug Association of the Philippines. A Position Paper on the Pharmaceutical Industry.
January 1988.
. A Guide to Understanding the Philippine Drug Industry. n.d.
Drug Monitor. September 1988.
Evans, R. "Supplier-Induced Demand: Some Empirical Evidence and Implications." In
The Economics of Health and Medical Care edited by M. Perlman. London:
Macmillan-IEA, 1973.
4Foster, S.D. "Supply and Use of Essential Drugs in Sub-Saharan Africa: Issues and
Possible Solutions." Backround paper for the African Health Policy, World Bank,
n.d.
Gabo, L and Williams, P. "Rural Tranquility?: Urban- Rural Differonees in Tranquilizer
Prescribing." Social Science and Medicine 10 (1986): 1059-66.
Gabunada, N. "The Drug Manufacturing Industry in the Philippines: Growth Record,
Issues and Problems, and Future Prospects." Masters' thesis, Center for Research and
Communication, 1983.
Haak, H. "Pharmaceuticals in Two Brazilian Villages: Lay Practices and Perceptions."
Social Science and Medicine 27, 3 (1987): 1415-27.
Hardon, A. "Symptom-Related Drug Use: Explanations of Community Health Workers
for the Observed Trends in Therapy Choice." Personal communication with second
author, 1988.
"The Use of Modem Pharmaceuticals in a Filipino Village: Doctors'
Prescription and Self-Medication." Social Science and Medicine 25,3 (1987): 227-92.
Hemminki, E. "The Effect of a Doctor's Personal Characteristics and Working
C'ireumstanees on the Prescribing of Psyehotropic Drugs." Medical Care 9 (1974):
383.
Herrin, A. and Bautista, M. "Health and Development: Determinants and Consequences."
In Survey of Philippine Development Research IlL Makati: Philippine Institute for
Development Studies, 1989.
Intercare. "Health Care Financing in the Philippines." In Health Care Financing.
Proceedings of the Regional Seminar on Health Care Financing, 27 July to 3 August
1987 held in Manila sponsored by the Asian Development Bank, the Economic
Development Institute of the World Bank and the East-West Center Population
Institute, Hawaii.
Kintanar, Q. and Chaneo, G. "The Philippine Pharmaceutical Industry." In C. Sepulveda
and Bumrungeheep (eds.), Pharmaceutical Industry in ASEAN Countries: A
Consultation. ESCAP Programme on Health and Society, Health Technical Paper
No. 42, 1980.
Kohn, R. and White, K. (eds.) Health Care: An International Study London: Oxford
University Press, 1976.
Leifman-Keil, E. "Consumer Protection, Incentives and Externalities in the Drug
Market." In The Economics of Health and Medical Care edited by M. Perlman.
London: MacMillan-lEA, 1973.
65
London School of Hygiene & Tropical Medicine 0-_ & Koninklijk Institute voor
de Tropen (KIT). An Evaluation of WHO's Action Programme on Essential Drugs.
Submitted to the Management Advisory Committe, The Action Programme on
Essential Drugs, 1989.
Manlayaon, O. "The Pricing of Medicine and Their Impact on the Urban Poor." Ateneo
Center for Social Policy and Public Affairs, 1988.
Maronde, R. et al. "A Study of Prescribing Patterns." Medical Care 9, 5 (1971): n.p.
Meneses, E. and Sepulvexia, C. (yds.) "A Prof'de of the Pharmaceutical Industry in
ASEAN Countries." UNAPDI Technical Paper No. 36, 1980.
National Economic Development Authority (NEDA). Compendium of Philippine Social
Statistics. Manila: NEDA, 1986.
Quijano, R. et al. Prescribing Habits of Physicians in Metro Manila. Quezon City:
National Council of Churches of the Philippines, 1985.
Quanico, U. "Anti-diarrheals in the Philippines." Drug Monitor June 1987.
Rabin, D. and Bush, P. "The Use of Medicines: Historical Trends and International
Comparisons." International Journal of Health Services 4 (1974): 61-87.
RP-UNIDO. "Papers for the Project on the Philippine Pharmaceutical Industry
Development Study." 1988.
Stolley, P. and Lasagna, L. "Prescribing Patterns of Physicians." Journal of Chronic
Diseases 22 (1969): 395-405.
StoRey, P. ctal. "I'he Relationship Between Physician Characteristics and Prescribing
Appropriateness." Medical Care 10, 1 (1972): 17-28.
Tan, M. "Rationalizing Drug Policies in the Philippines." Health Policy Development
Lecture Series No. 3. Health Action Information Network, 1986.
Tordesillas, E. and Senturias, E. "Prescribing Patterns of Medical Personnel in a
Teaching Hospital." The Filipino Family Physician 19(1), January-March 1981.
Tucker, D. The World Health Market: The Future of the Phamaceutical Industry
London: Euromonitor Publications, Ltd., 1984.
World Health Organization (WHO). The WorldDrug Situation, 1988.
Yudkin, J. "Use and Misuse of Drugs in the Third World." Danish Medical Bulletin 31, 1
(November 1984).
WORKINGPAPERS
1991 1992
W.P. No. 91-09 AgrarianReform, the Cattle W.P. No. 92-01 Forest andLand-use
InduslryandRuralFinancing Practices in Philippine
Markets. Uplands:National Level
Achilles C. Costales Analysis Based on
August 1991 Bight Villages
W.P. No. 91-10 InterlinkedCreditandTenancy Marian S. delos Angeles
Arrangements:A Slateof the and Lota A, YFubay
ArtReview. February1992; 76 pp.
Robert R. Teh, Jr. W.P. No. 92-02 Performance,Competitiveness
August 1991; 28 pp. andStructureof Philippine
W.P. No. 91-11 Cre_t Marketsin theFisheries ManufacturingIndustries:
Sector underthe CARP:.A A Research Design
Review of Literatmeand Gwendolyn R. Tecson
ConceptualFramewod_, April 1992
Gilberto M. Llanto and W.P. No. 92-03 MeasuringBenefits from
Marife T. Magno Resoun:es Conservation:
August 1991; 49 pp. The Case of the Central
W.P. No. 91-12 Growthand Dynamics of Visayas Regional Projects
Microenterprises:Does Marian S. delos Angeles
Finance Matter'/ April 1992
Lucila A. Lapar W.P. No.92-04 Intergovetnmcnlal Fiscal
August 1991; 28 pp, Relations, Fiscal Federalism
W.P. No. 91-13 A GeneralAssessment of the and Economic Development
ComprehensiveAgrarian in the Philippines
ReformProgram. Rosario G. Manasan
Lourdes Saulo-Adrlano May 1992
August 1991 W.P. No. 92-05 Determinants andPolicy
W.P. No. 91-14 Impact of AgrarianReform on Implications of Drag
Landowners:A Review of Utilization in the Philippines
Literatureand Conceptual Ma. Cristina G. Bautista
Framework. June 1992
Gilberto M. Llanto and W.P. No. 92-06 Factor=Affecting the Demand
Clarence G. Dingcong forHealth Sin-vices.inthe
August 1991 Philippines
W.P. No. 91-15 Linkages, Poverty andIncome Panfila Ching
Distribution. June 1992
Arsenio M. Balisacan
August 1991
W,P_No. 91-16 GenderIssues in Agrarian
Reform and RuralNonFann
Eaterprise.
Ma. Piedad S. Geron
August 1991
W.P. No. 91-17 A Studyon RuralLabor
Markets,Rural NonFarm
Enterprisesand Agrarian
Reform in the Philippines: A PHILIPPINEINSTITUTEFORDEVELOPMENTSTUDIES
Review of Lite_ure, NEDAsa MakatlBuilding,106 AmorsoloSt., LegasplVillage
Ma. Teresa Sanches 1229Makatl,MetroManila
August 1991; 28 pp. Philippines
  
This work is licensed under a 
Creative Commons  
Attribution – NonCommercial - NoDerivs 3.0 License. 
 
 
 
To view a copy of the license please see: 
http://creativecommons.org/licenses/by-nc-nd/3.0/ 
 
